{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# https://stackoverflow.com/questions/28289699/python-web-scraping-for-javascript-generated-content?noredirect=1&lq=1\n",
    "# https://www.mikejohnpage.com/blog/rendering-javascript-content-using-python-selenium-and-a-headless-browser/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Import modules\n",
    "import requests\n",
    "\n",
    "from selenium import webdriver\n",
    "from selenium.webdriver.firefox.options import Options\n",
    "from selenium.webdriver.support.wait import WebDriverWait\n",
    "\n",
    "from datetime import datetime\n",
    "\n",
    "from bs4 import BeautifulSoup\n",
    "import lxml\n",
    "\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "base_url = 'https://clinicaltrials.gov'\n",
    "content_url = '%s/ct2/about-studies/glossary'%base_url\n",
    "js_url = '%s/ct2/html/js/main-glossary.js?v=44'%base_url"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "# robots.txt - robot exclusion file - back-end server version - no robots!\n",
      "# ========================================================================\n",
      "User-agent: htdig/3.1.6\n",
      "Disallow: /cgi-bin\n",
      "Disallow: /entrez\n",
      "Disallow: /COG\n",
      "Disallow: /Entrez\n",
      "Disallow: /myncbi\n",
      "Disallow: /sutils\n",
      "Disallow: /Taxonomy/Selector\n",
      "Disallow: /Taxonomy/CommonTree\n",
      "Disallow: /entrez/sutils\n",
      "Disallow: /mapview\n",
      "Disallow: /blast/BlastAlign.cgi \n",
      "Disallow: /blast/bl2seq/wblast2.cgi\n",
      "Disallow: /portal\n",
      "Disallow: /pmc/utilities/\n",
      "Disallow: /pmc/issues/\n",
      "Disallow: /pmc/articles/\n",
      "Disallow: /pmc/ivip/\n",
      "Disallow: /pmc/articlerender.fcgi\n",
      "Disallow: /pmc/pagerender.fcgi\n",
      "Disallow: /pmc/picrender.fcgi\n",
      "Disallow: /pmc/tocrender.fcgi\n",
      "Disallow: /pmc/*report=\n",
      "Disallow: /pmc/*page=\n",
      "Disallow: /pmc/articles/*/citedby/\n",
      "Disallow: /pmc/publisherportal/api/\n",
      "Disallow: /pmc/publisherportal/application/\n",
      "Disallow: /pmc/publisherportal/download\n",
      "Disallow: /pmc/publisherportal/journalmanager/\n",
      "Disallow: /labs/pmc/\n",
      "Disallow: /geo/tools\n",
      "Disallow: /projects/geo/tools\n",
      "Disallow: /geo/download\n",
      "Disallow: /projects/geo/download\n",
      "Disallow: /projects/gtr/gt\n",
      "Disallow: /Structure/flink/flink.cgi\n",
      "Disallow: /Structure/vast/vastsrv.cgi\n",
      "Disallow: /viewvc\n",
      "\n",
      "User-agent: Baiduspider\n",
      "Disallow: /cgi-bin\n",
      "Disallow: /entrez\n",
      "Disallow: /COG\n",
      "Disallow: /Entrez\n",
      "Disallow: /myncbi\n",
      "Disallow: /sutils\n",
      "Disallow: /Taxonomy/Selector\n",
      "Disallow: /Taxonomy/CommonTree\n",
      "Disallow: /entrez/sutils\n",
      "Disallow: /mapview\n",
      "Disallow: /blast/BlastAlign.cgi\n",
      "Disallow: /blast/bl2seq/wblast2.cgi\n",
      "Disallow: /portal\n",
      "Disallow: /pmc/utilities/\n",
      "Disallow: /pmc/issues/\n",
      "Disallow: /pmc/articles/\n",
      "Disallow: /pmc/ivip/\n",
      "Disallow: /pmc/articlerender.fcgi\n",
      "Disallow: /pmc/pagerender.fcgi\n",
      "Disallow: /pmc/picrender.fcgi\n",
      "Disallow: /pmc/tocrender.fcgi\n",
      "Disallow: /pmc/*report=\n",
      "Disallow: /pmc/*page=\n",
      "Disallow: /pmc/articles/*/citedby/\n",
      "Disallow: /pmc/publisherportal/api/\n",
      "Disallow: /pmc/publisherportal/application/\n",
      "Disallow: /pmc/publisherportal/download\n",
      "Disallow: /pmc/publisherportal/journalmanager/\n",
      "Disallow: /labs/pmc/\n",
      "Disallow: /geo/tools\n",
      "Disallow: /projects/geo/tools\n",
      "Disallow: /geo/download\n",
      "Disallow: /projects/geo/download\n",
      "Disallow: /projects/gtr/gt\n",
      "Disallow: /Structure/flink/flink.cgi\n",
      "Disallow: /Structure/vast/vastsrv.cgi\n",
      "Disallow: /viewvc\n",
      "\n",
      "User-agent: Googlebot\n",
      "Disallow: /cgi-bin\n",
      "Disallow: /COG\n",
      "Disallow: /mailman\n",
      "Disallow: /sutils\n",
      "Disallow: /entrez/viewer.fcgi\n",
      "Disallow: /Taxonomy/Selector\n",
      "Disallow: /Taxonomy/CommonTree\n",
      "Disallow: /entrez/sutils\n",
      "Disallow: /SAGE\n",
      "Disallow: /SNP\n",
      "Disallow: /IEB/ToolBox/SB\n",
      "Disallow: /Structure/dgs\n",
      "Disallow: /Structure/VA\n",
      "Disallow: /Structure/cblast/cblast.cgi\n",
      "Disallow: /Coffeebreak\n",
      "Disallow: /gorf\n",
      "Disallow: /mapview\n",
      "Disallow: /myncbi\n",
      "Disallow: /blast/BlastAlign.cgi \n",
      "Disallow: /blast/bl2seq/wblast2.cgi\n",
      "Disallow: /entrez/eutils\n",
      "Disallow: /entrez/utils\n",
      "Disallow: /portal\n",
      "Disallow: /pmc/utilities/\n",
      "Disallow: /pmc/*/bin/\n",
      "Disallow: /pmc/*/pdf/\n",
      "Disallow: /pmc/*/equ/\n",
      "Disallow: /pmc/*.cgi\n",
      "Disallow: /pmc/*report=\n",
      "Disallow: /pmc/*page=\n",
      "Disallow: /pmc/articles/*/citedby/\n",
      "Disallow: /pmc/publisherportal/api/\n",
      "Disallow: /pmc/publisherportal/application/\n",
      "Disallow: /pmc/publisherportal/download\n",
      "Disallow: /pmc/publisherportal/journalmanager/\n",
      "Disallow: /labs/pmc/\n",
      "Disallow: /geo/tools\n",
      "Disallow: /projects/geo/tools\n",
      "Disallow: /geo/download\n",
      "Disallow: /projects/geo/download\n",
      "Disallow: /projects/gtr/gt\n",
      "Disallow: /Structure/flink/flink.cgi\n",
      "Disallow: /Structure/vast/vastsrv.cgi\n",
      "Disallow: /viewvc\n",
      "Disallow: /clone/library/genomic/organisms\n",
      "Allow: /portal/portal3rc.fcgi/*/*.js\n",
      "Allow: /portal/portal3rc.fcgi/*/*.css\n",
      "\n",
      "User-agent: Teleport Pro\n",
      "Disallow: /cgi-bin\n",
      "Disallow: /entrez\n",
      "Disallow: /COG\n",
      "Disallow: /Entrez\n",
      "Disallow: /myncbi\n",
      "Disallow: /mailman\n",
      "Disallow: /sutils\n",
      "Disallow: /Taxonomy/Selector\n",
      "Disallow: /Taxonomy/CommonTree\n",
      "Disallow: /entrez/sutils\n",
      "Disallow: /mapview\n",
      "Disallow: /blast/BlastAlign.cgi \n",
      "Disallow: /blast/bl2seq/wblast2.cgi\n",
      "Disallow: /portal\n",
      "Disallow: /pmc/utilities/\n",
      "Disallow: /pmc/issues/\n",
      "Disallow: /pmc/articles/\n",
      "Disallow: /pmc/ivip/\n",
      "Disallow: /pmc/articlerender.fcgi\n",
      "Disallow: /pmc/pagerender.fcgi\n",
      "Disallow: /pmc/picrender.fcgi\n",
      "Disallow: /pmc/tocrender.fcgi\n",
      "Disallow: /pmc/publisherportal/api/\n",
      "Disallow: /pmc/publisherportal/application/\n",
      "Disallow: /pmc/publisherportal/download\n",
      "Disallow: /pmc/publisherportal/journalmanager/\n",
      "Disallow: /labs/pmc/\n",
      "Disallow: /geo/tools\n",
      "Disallow: /projects/geo/tools\n",
      "Disallow: /geo/download\n",
      "Disallow: /projects/geo/download\n",
      "Disallow: /projects/gtr/gt\n",
      "Disallow: /Structure/flink/flink.cgi\n",
      "Disallow: /Structure/vast/vastsrv.cgi\n",
      "Disallow: /viewvc\n",
      "\n",
      "User-agent: yacybot\n",
      "Disallow: * \n",
      "\n",
      "User-agent: Browsershots\n",
      "Disallow:\n",
      "\n",
      "User-agent: Slurp\n",
      "Crawl-delay: 1\n",
      "Disallow: /cgi-bin\n",
      "Disallow: /entrez\n",
      "Disallow: /COG\n",
      "Disallow: /Entrez\n",
      "Disallow: /myncbi\n",
      "Disallow: /mailman\n",
      "Disallow: /sutils\n",
      "Disallow: /Taxonomy/Selector\n",
      "Disallow: /Taxonomy/CommonTree\n",
      "Disallow: /entrez/sutils\n",
      "Disallow: /mapview\n",
      "Disallow: /blast/BlastAlign.cgi\n",
      "Disallow: /blast/bl2seq/wblast2.cgi\n",
      "Disallow: /SAGE\n",
      "Disallow: /SNP\n",
      "Disallow: /portal\n",
      "Disallow: /pmc/utilities/\n",
      "Disallow: /pmc/*/bin/\n",
      "Disallow: /pmc/*/pdf/\n",
      "Disallow: /pmc/*/equ/\n",
      "Disallow: /pmc/*.cgi\n",
      "Disallow: /pmc/*report=\n",
      "Disallow: /pmc/*page=\n",
      "Disallow: /pmc/articles/*/citedby/\n",
      "Disallow: /pmc/publisherportal/api/\n",
      "Disallow: /pmc/publisherportal/application/\n",
      "Disallow: /pmc/publisherportal/download\n",
      "Disallow: /pmc/publisherportal/journalmanager/\n",
      "Disallow: /labs/pmc/\n",
      "Disallow: /geo/tools\n",
      "Disallow: /projects/geo/tools\n",
      "Disallow: /geo/download\n",
      "Disallow: /projects/geo/download\n",
      "Disallow: /projects/gtr/gt\n",
      "Disallow: /Structure/flink/flink.cgi\n",
      "Disallow: /Structure/vast/vastsrv.cgi\n",
      "Disallow: /viewvc\n",
      "\n",
      "User-agent: Twitterbot\n",
      "Disallow: *\n",
      "Allow: /pmc/articles\n",
      "Allow: /books/NBK*\n",
      "\n",
      "User-agent: Exabot\n",
      "Disallow: /Structure\n",
      "\n",
      "\n",
      "User-agent: bingbot\n",
      "Disallow: /cgi-bin\n",
      "Disallow: /entrez\n",
      "Disallow: /COG\n",
      "Disallow: /Entrez\n",
      "Disallow: /myncbi\n",
      "Disallow: /mailman\n",
      "Disallow: /sutils\n",
      "Disallow: /Taxonomy/Selector\n",
      "Disallow: /Taxonomy/CommonTree\n",
      "Disallow: /entrez/sutils\n",
      "Disallow: /mapview\n",
      "Disallow: /SAGE\n",
      "Disallow: /SNP\n",
      "Disallow: /blast/BlastAlign.cgi\n",
      "Disallow: /blast/bl2seq/wblast2.cgi\n",
      "Disallow: /portal\n",
      "Disallow: /pmc/utilities/\n",
      "Disallow: /pmc/*/bin/\n",
      "Disallow: /pmc/*/pdf/\n",
      "Disallow: /pmc/*/equ/\n",
      "Disallow: /pmc/*.cgi\n",
      "Disallow: /pmc/*report=\n",
      "Disallow: /pmc/*page=\n",
      "Disallow: /pmc/articles/*/citedby/\n",
      "Disallow: /pmc/publisherportal/api/\n",
      "Disallow: /pmc/publisherportal/application/\n",
      "Disallow: /pmc/publisherportal/download\n",
      "Disallow: /pmc/publisherportal/journalmanager/\n",
      "Disallow: /labs/pmc/\n",
      "Disallow: /geo/tools\n",
      "Disallow: /projects/geo/tools\n",
      "Disallow: /geo/download\n",
      "Disallow: /projects/geo/download\n",
      "Disallow: /projects/gtr/gt\n",
      "Disallow: /Structure/flink/flink.cgi\n",
      "Disallow: /Structure/vast/vastsrv.cgi\n",
      "Disallow: /viewvc\n",
      "Disallow: /clone/library/genomic/organisms\n",
      "Allow: /portal/portal3rc.fcgi/*/*.js\n",
      "Allow: /portal/portal3rc.fcgi/*/*.css\n",
      "\n",
      "User-agent: *\n",
      "Crawl-delay: 5\n",
      "Disallow: /cgi-bin\n",
      "Disallow: /entrez\n",
      "Disallow: /COG\n",
      "Disallow: /Entrez\n",
      "Disallow: /myncbi\n",
      "Disallow: /mailman\n",
      "Disallow: /sutils\n",
      "Disallow: /Taxonomy/Selector\n",
      "Disallow: /Taxonomy/CommonTree\n",
      "Disallow: /entrez/sutils\n",
      "Disallow: /mapview\n",
      "Disallow: /SAGE\n",
      "Disallow: /SNP\n",
      "Disallow: /blast/BlastAlign.cgi \n",
      "Disallow: /blast/bl2seq/wblast2.cgi\n",
      "Disallow: /portal\n",
      "Disallow: /pmc/utilities/\n",
      "Disallow: /pmc/issues/\n",
      "Disallow: /pmc/articles/\n",
      "Disallow: /pmc/ivip/\n",
      "Disallow: /pmc/articlerender.fcgi\n",
      "Disallow: /pmc/pagerender.fcgi\n",
      "Disallow: /pmc/picrender.fcgi\n",
      "Disallow: /pmc/tocrender.fcgi\n",
      "Disallow: /pmc/*report=\n",
      "Disallow: /pmc/*page=\n",
      "Disallow: /pmc/articles/*/citedby/\n",
      "Disallow: /pmc/publisherportal/api/\n",
      "Disallow: /pmc/publisherportal/application/\n",
      "Disallow: /pmc/publisherportal/download\n",
      "Disallow: /pmc/publisherportal/journalmanager/\n",
      "Disallow: /labs/pmc/\n",
      "Disallow: /geo/tools\n",
      "Disallow: /projects/geo/tools\n",
      "Disallow: /geo/download\n",
      "Disallow: /projects/geo/download\n",
      "Disallow: /projects/gtr/gt\n",
      "Disallow: /Structure/flink/flink.cgi\n",
      "Disallow: /Structure/vast/vastsrv.cgi\n",
      "Disallow: /viewvc\n",
      "Disallow: /clone/library/genomic/organisms\n",
      "Allow: /portal/portal3rc.fcgi/*/*.js\n",
      "Allow: /portal/portal3rc.fcgi/*/*.css\n",
      "\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=assembly/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=biosystems/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=books/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=cdd/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=clinvar/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=gene/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=medgen/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=mesh/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=ncbi/sitemap.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=nlmcatalog/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=pmc/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/Traces/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/Structure/sitemaps/mmdb/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/Structure/sitemaps/cdd/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/Structure/sitemaps/sparcle/sitemap.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/Structure/sitemaps/genome/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=sra/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/escan?p=snp/sitemap_index.xml\n",
      "Sitemap: https://www.ncbi.nlm.nih.gov/core/assets/osiris/files/sitemap.xml\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# HTTP request robots.txt file and check permissions\n",
    "r = requests.get('%s/robots.txt'%base_url)\n",
    "print(r.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# C:\\Users\\172470\\scripts\\geckodriver-v0.29.0-win64\n",
    "\n",
    "# Requests library cannot return rendered javascript content, only the unmodified DOM (static web page).\n",
    "# Use selenium and a web driver to automate a web browser and return rendered javascript content (dynamic web page).\n",
    "# Initiate headless Firefox driver\n",
    "options = Options()\n",
    "options.headless = True\n",
    "driver = webdriver.Firefox(executable_path = 'C:/Users/172470/scripts/geckodriver-v0.29.0-win64/geckodriver', options = options)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "driver.get(content_url)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Retrieve page source\n",
    "soup = BeautifulSoup(driver.page_source, 'lxml')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Quit driver\n",
    "driver.quit()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<html class=\"fa-events-icons-ready\" lang=\"en\" xmlns=\"https://www.w3.org/1999/xhtml\"><head>\n",
       "<meta content=\"IE=edge\" http-equiv=\"X-UA-Compatible\"/>\n",
       "<meta content=\"width=device-width, initial-scale=1\" name=\"viewport\"/>\n",
       "<meta content=\"text/html; charset=utf-8\" http-equiv=\"content-type\"/>\n",
       "<meta content=\"origin-when-cross-origin\" name=\"referrer\"/>\n",
       "<title>Glossary of Common Site Terms - ClinicalTrials.gov</title>\n",
       "<!-- Open Graph data -->\n",
       "<meta content=\"article\" property=\"og:type\"/>\n",
       "<meta content=\"Glossary of Common Site Terms - ClinicalTrials.gov\" property=\"og:title\"/>\n",
       "<meta content=\"https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-logo.png\" property=\"og:image\"/>\n",
       "<link href=\"/ct2/html/images/favicon.ico\" rel=\"shortcut icon\"/>\n",
       "<link href=\"/ct2/html/images/apple-touch-icon-144x144.png\" rel=\"apple-touch-icon-precomposed\" sizes=\"144x144\"/>\n",
       "<link href=\"/ct2/html/images/apple-touch-icon-114x114.png\" rel=\"apple-touch-icon-precomposed\" sizes=\"114x114\"/>\n",
       "<link href=\"/ct2/html/images/apple-touch-icon-72x72.png\" rel=\"apple-touch-icon-precomposed\" sizes=\"72x72\"/>\n",
       "<link href=\"/ct2/html/images/apple-touch-icon-precomposed.png\" rel=\"apple-touch-icon-precomposed\"/>\n",
       "<link href=\"/ct2/html/images/apple-touch-icon.png\" rel=\"apple-touch-icon-precomposed\"/>\n",
       "<link href=\"/ct2/html/jquery/css/superfish.css?v=44\" media=\"screen\" rel=\"stylesheet\" type=\"text/css\"/>\n",
       "<link href=\"/ct2/html/jquery/css/superfish-vertical.css?v=44\" media=\"screen\" rel=\"stylesheet\" type=\"text/css\"/>\n",
       "<link href=\"/ct2/html/css/glossary.css?v=44\" rel=\"stylesheet\" type=\"text/css\"/>\n",
       "<link href=\"/ct2/html/css/base.css?v=44\" rel=\"stylesheet\" type=\"text/css\"/>\n",
       "<link href=\"/ct2/html/css/print.css?v=44\" media=\"print\" rel=\"stylesheet\" type=\"text/css\"/>\n",
       "<link href=\"/ct2/html/css/w3-ct.css?v=44\" rel=\"stylesheet\" type=\"text/css\"/>\n",
       "<!--[if lt IE 9]>\n",
       "\t<link rel=\"stylesheet\" href=\"/ct2/html/css/w3-ct-oldIE.css?v=44\" type=\"text/css\" />\n",
       "  <![endif]-->\n",
       "<link href=\"https://use.fontawesome.com\" rel=\"preconnect\"/>\n",
       "<link href=\"https://www.ncbi.nlm.nih.gov\" rel=\"preconnect\"/>\n",
       "<script src=\"https://use.fontawesome.com/20a31629ec.js\"></script><link href=\"https://use.fontawesome.com/20a31629ec.css\" media=\"all\" rel=\"stylesheet\"/>\n",
       "<!--[if lte IE 7]>\n",
       "       <link href=\"/ct2/html/css/target-IE7-and-below.css\" rel=\"stylesheet\" type=\"text/css\">\n",
       "<![endif]-->\n",
       "<style type=\"text/css\">\n",
       "  h2 \n",
       "  {\n",
       "      background-color: #EAEAEA;\n",
       "  }\n",
       "</style>\n",
       "<script src=\"/ct2/html/jquery/js/jquery.min.js?v=44\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "<script async=\"\" src=\"/ct2/html/jquery/js/superclick.min.js?v=44\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "<script async=\"\" src=\"/ct2/html/js/ct.js?v=44\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "<script async=\"\" src=\"/ct2/html/js/ctmenu.js?v=44\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "<meta content=\"4ec73c0205e3ef26_793f8SID\" name=\"ncbi_sid\"/>\n",
       "<meta content=\"ctgov\" name=\"ncbi_app\"/>\n",
       "<meta content=\"ctgov\" name=\"ncbi_db\"/>\n",
       "<meta content=\"about\" name=\"ncbi_pdid\"/>\n",
       "<meta content=\"about_studies_glossary\" name=\"ncbi_pcid\"/>\n",
       "<meta content=\"R99025CC\" name=\"ncbi_ctreqid\"/>\n",
       "<meta content=\"S9901tYd\" name=\"ncbi_ctsessid\"/>\n",
       "<meta content=\"I114j1yNb\" name=\"ncbi_ctipid\"/>\n",
       "<meta content=\"w12\" name=\"ncbi_cthost\"/>\n",
       "<script async=\"1\" src=\"https://www.google-analytics.com/analytics.js\"></script><style>.ncbi-alerts .ncbi-alert__shutdown-outer { position: relative; background-color: #f4e3db; border-left: 8px solid #d54309;  background-image: url(\"data:image/svg+xml,%3C%3Fxml version='1.0' encoding='UTF-8'%3F%3E%3Csvg xmlns='http://www.w3.org/2000/svg' width='126' height='126' viewBox='0 0 126 126'%3E%3Cpath fill='%231B1B1B' d='M117.18,31.592 C111.585,22.006 103.995,14.416 94.409,8.821 C84.821,3.226 74.354,0.429 63.001,0.429 C51.649,0.429 41.18,3.226 31.593,8.821 C22.006,14.415 14.416,22.005 8.821,31.592 C3.225,41.179 0.428,51.649 0.428,63 C0.428,74.351 3.226,84.82 8.82,94.408 C14.415,103.992 22.005,111.584 31.592,117.179 C41.179,122.774 51.648,125.571 63,125.571 C74.352,125.571 84.822,122.774 94.408,117.179 C103.994,111.585 111.584,103.994 117.179,94.408 C122.773,84.82 125.57,74.35 125.57,63 C125.57,51.649 122.773,41.178 117.18,31.592 Z M73.43,102.025 C73.43,102.786 73.184,103.423 72.696,103.939 C72.208,104.455 71.61,104.712 70.903,104.712 L55.26,104.712 C54.554,104.712 53.929,104.441 53.386,103.898 C52.843,103.355 52.572,102.73 52.572,102.025 L52.572,86.546 C52.572,85.84 52.843,85.215 53.386,84.672 C53.929,84.129 54.554,83.858 55.26,83.858 L70.903,83.858 C71.61,83.858 72.209,84.116 72.696,84.631 C73.184,85.149 73.43,85.785 73.43,86.546 L73.43,102.025 Z M73.266,73.999 C73.211,74.542 72.927,75.018 72.412,75.425 C71.895,75.832 71.258,76.035 70.498,76.035 L55.425,76.035 C54.664,76.035 54.012,75.832 53.469,75.425 C52.926,75.018 52.654,74.542 52.654,73.999 L51.269,23.404 C51.269,22.751 51.54,22.263 52.083,21.937 C52.627,21.503 53.279,21.285 54.039,21.285 L71.965,21.285 C72.726,21.285 73.377,21.502 73.92,21.937 C74.463,22.263 74.733,22.752 74.733,23.404 L73.266,73.999 Z'/%3E%3C/svg%3E%0A\");}.ncbi-alerts .ncbi-alert__info-outer { position: relative; background-color: #e7f6f8; border-left: 8px solid #00bde3; background-image: url(\"data:image/svg+xml,%3C%3Fxml version='1.0' encoding='UTF-8'%3F%3E%3Csvg xmlns='http://www.w3.org/2000/svg' width='126' height='126' viewBox='0 0 126 126'%3E%3Cpath fill='%231B1B1B' d='M117.18,31.592 C111.585,22.006 103.995,14.416 94.409,8.821 C84.821,3.226 74.354,0.429 63.001,0.429 C51.649,0.429 41.179,3.226 31.593,8.821 C22.006,14.415 14.416,22.005 8.821,31.592 C3.225,41.179 0.428,51.649 0.428,63 C0.428,74.352 3.226,84.82 8.82,94.408 C14.415,103.993 22.005,111.584 31.592,117.179 C41.179,122.774 51.648,125.571 63,125.571 C74.352,125.571 84.822,122.774 94.408,117.179 C103.994,111.585 111.584,103.994 117.179,94.408 C122.773,84.821 125.57,74.351 125.57,63 C125.57,51.648 122.773,41.178 117.18,31.592 Z M52.572,16.071 C52.572,15.31 52.816,14.686 53.305,14.197 C53.794,13.709 54.419,13.464 55.179,13.464 L70.823,13.464 C71.583,13.464 72.208,13.709 72.695,14.197 C73.183,14.686 73.429,15.31 73.429,16.071 L73.429,29.107 C73.429,29.867 73.183,30.492 72.695,30.98 C72.208,31.469 71.583,31.713 70.823,31.713 L55.179,31.713 C54.419,31.713 53.794,31.469 53.305,30.98 C52.816,30.492 52.572,29.867 52.572,29.107 L52.572,16.071 Z M83.857,102.107 C83.857,102.867 83.611,103.492 83.124,103.979 C82.637,104.468 82.012,104.712 81.25,104.712 L44.75,104.712 C43.989,104.712 43.365,104.468 42.876,103.979 C42.387,103.491 42.143,102.866 42.143,102.106 L42.143,89.07 C42.143,88.308 42.387,87.685 42.876,87.196 C43.365,86.708 43.99,86.463 44.75,86.463 L52.572,86.463 L52.572,60.392 L44.75,60.392 C43.989,60.392 43.365,60.148 42.876,59.659 C42.387,59.171 42.143,58.546 42.143,57.785 L42.143,44.75 C42.143,43.989 42.387,43.365 42.876,42.876 C43.365,42.387 43.99,42.143 44.75,42.143 L70.823,42.143 C71.583,42.143 72.208,42.387 72.695,42.876 C73.183,43.365 73.429,43.989 73.429,44.75 L73.429,86.464 L81.249,86.464 C82.01,86.464 82.635,86.709 83.123,87.197 C83.61,87.685 83.856,88.31 83.856,89.071 L83.856,102.107 L83.857,102.107 Z'/%3E%3C/svg%3E\");}.ncbi-alerts div[class$=\"-outer\"]{background-position: 28px 20px;  background-size: 32px 32px;  background-repeat: no-repeat;padding:20px 20px 20px 28px;}.ncbi-alerts div[class$=\"-inner\"]{padding-left: 52px; padding-right: 52px;}@media (max-width: 639px){.ncbi-alerts div[class$=\"outer\"]{background-position: 15px 20px;}.ncbi-alerts div[class$=\"-inner\"]{padding-left: 0px; padding-right: 0px; padding-top: 40px;}}.ncbi-alerts button.close{cursor: pointer;position:absolute; top: 10px; right: 20px; width: 36px; height: 32px; border:0; background-color: transparent; background-image: url(\"data:image/svg+xml,%3Csvg version='1.2' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' overflow='visible' preserveAspectRatio='none' viewBox='0 0 24 24' width='32' height='32'%3E%3Cg%3E%3Cpath xmlns:default='http://www.w3.org/2000/svg' id='window-close' d='M14.9,16.42c-0.13,0.13-0.33,0.14-0.47,0.01c0,0-0.01-0.01-0.01-0.01L12,14l-2.43,2.42 c-0.13,0.13-0.33,0.14-0.47,0.01c0,0-0.01-0.01-0.01-0.01L7.58,14.9c-0.13-0.13-0.14-0.33-0.01-0.47c0,0,0.01-0.01,0.01-0.01L10,12 L7.58,9.57C7.45,9.45,7.44,9.24,7.57,9.1c0,0,0.01-0.01,0.01-0.01L9.1,7.58c0.13-0.13,0.33-0.14,0.47-0.01c0,0,0.01,0.01,0.01,0.01 L12,10l2.43-2.43c0.13-0.13,0.33-0.14,0.47-0.01c0,0,0.01,0.01,0.01,0.01l1.51,1.53c0.13,0.13,0.14,0.33,0.01,0.47 c0,0-0.01,0.01-0.01,0.01L14,12l2.43,2.43c0.13,0.13,0.14,0.33,0.01,0.47c0,0-0.01,0.01-0.01,0.01L14.9,16.42L14.9,16.42z M20.84,4.49C20.53,4.17,20.1,3.99,19.66,4H4.34C3.42,4,2.67,4.75,2.67,5.67l0,0v12.66c0,0.92,0.75,1.67,1.67,1.67l0,0h15.32 c0.92,0,1.67-0.75,1.67-1.67l0,0V5.67C21.34,5.23,21.16,4.8,20.84,4.49z' style='fill: rgb(33, 33, 33);' vector-effect='non-scaling-stroke'/%3E%3C/g%3E%3C/svg%3E\");background-size: 32px 32px; background-repeat:no-repeat;background-position:center center}.ncbi-alerts button.close:focus{ outline: 1px dotted #000000;}@media (max-width: 639px){.ncbi-alerts button.close{right: 0px;}}.ncbi-alerts p{margin-bottom: 0px; margin-top: 0px; font-size: 18px; line-height: 28px;}.ncbi-alerts .list-items > p{font-size: 0.94em; display: inline;}.ncbi-alerts .list-items > p a {font-weight: 700;}.ncbi-alerts .list-items > p:not(:last-child)::after{margin:0 8px;content:'|'}@media (min-width: 768px) and (max-width: 991px){.ncbi-alerts .list-items > p:nth-child(2)::after{content:'\\a'!important;white-space: pre;}}@media(max-width: 767px){.ncbi-alerts .list-items > p{display:block;}.ncbi-alerts .list-items > p::after{content:''!important;}}</style></head>\n",
       "<body> <script src=\"https://clinicaltrials.gov/html/jquery/js/jquery.min.js\" type=\"text/javascript\">&#xA0;</script>\n",
       "<script type=\"text/javascript\">\n",
       "    jQuery.getScript(\"https://www.ncbi.nlm.nih.gov/core/alerts/alerts.js\", function () {\n",
       "      galert(['#alert_banner', 'body &gt; *:nth-child(1)'])});\n",
       "</script>\n",
       "<div id=\"alert_banner\" style=\"margin-bottom: 0px;\"></div><div aria-label=\"Alert\" class=\"ncbi-alerts nCoV_shutdown\" id=\"nCoV_shutdown\" role=\"region\" style=\"margin-bottom: 0px;\"><div class=\"ncbi-alert__shutdown-outer\"><div class=\"ncbi-alert__shutdown-inner\"><p><strong>COVID-19 is an emerging, rapidly evolving situation.</strong></p><div class=\"list-items\"><p><a href=\"https://www.coronavirus.gov\">Public health information (CDC)</a></p><p><a href=\"https://covid19.nih.gov/\">Research information (NIH)</a></p><p><a href=\"https://www.ncbi.nlm.nih.gov/sars-cov-2/\">SARS-CoV-2 data (NCBI)</a></p><p><a href=\"https://combatcovid.hhs.gov/\">Prevention and treatment information (HHS)</a></p></div></div><button aria-controls=\"nCoV_shutdown\" aria-label=\"Close Alert\" class=\"close\" type=\"button\">Â </button></div></div>\n",
       "<!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET-->\n",
       "<script type=\"text/javascript\">\n",
       "(function(){var g=function(e,h,f,g){\n",
       "this.get=function(a){for(var a=a+\"=\",c=document.cookie.split(\";\"),b=0,e=c.length;b<e;b++){for(var d=c[b];\" \"==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};\n",
       "this.set=function(a,c){var b=\"\",b=new Date;b.setTime(b.getTime()+6048E5);b=\"; expires=\"+b.toGMTString();document.cookie=a+\"=\"+c+b+\"; path=/; \"};\n",
       "this.check=function(){var a=this.get(f);if(a)a=a.split(\":\");else if(100!=e)\"v\"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(\":\"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case \"v\":return!1;case \"r\":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(\":\")),!c}return!0};\n",
       "this.go=function(){if(this.check()){var a=document.createElement(\"script\");a.type=\"text/javascript\";a.src=g+ \"&t=\" + (new Date()).getTime();document.body&&document.body.appendChild(a)}};\n",
       "this.start=function(){var a=this;window.addEventListener?window.addEventListener(\"load\",function(){a.go()},!1):window.attachEvent&&window.attachEvent(\"onload\",function(){a.go()})}};\n",
       "try{(new g(100,\"r\",\"QSI_S_ZN_7WHWRcRMBs9xWYd\",\"https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd\")).start()}catch(i){}})();\n",
       "</script><div id=\"ZN_7WHWRcRMBs9xWYd\"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div>\n",
       "<!--END WEBSITE FEEDBACK SNIPPET-->\n",
       "<div aria-describedby=\"glossary-result\" aria-hidden=\"true\" class=\"glossary\" id=\"glossary\">\n",
       "<button class=\"js-glossary-close button button--close js-glossary-toggle usa-button-unstyled\" tabindex=\"-1\" title=\"Close glossary\"><span class=\"usa-sr-only\">Hide glossary</span>\n",
       "<i aria-hidden=\"true\" class=\"fa fa-times\"></i>\n",
       "</button>\n",
       "<h4 class=\"glossary-heading\">Glossary</h4>\n",
       "<p>\n",
       "  Study record managers: refer to the <a href=\"https://clinicaltrials.gov/ct2/manage-recs/resources#DataElement\" tabindex=\"-1\"><span style=\"text-decoration:underline\">Data Element Definitions</span></a> if submitting registration or results information.\n",
       "  </p>\n",
       "<p>\n",
       "<label class=\"label\" for=\"glossary-search\">Search for terms</label>\n",
       "</p>\n",
       "<span class=\"clearable-input\">\n",
       "<input class=\"js-glossary-search\" id=\"glossary-search\" tabindex=\"-1\"/>\n",
       "<span class=\"js-glossary-clear button js-glossary-toggle usa-button-unstyled\" data-clear-input=\"\">x</span>\n",
       "</span>\n",
       "<div class=\"glossary__content\" id=\"glossary-result\">\n",
       "<ul class=\"js-glossary-list\"><li class=\"glossary__item\"><button aria-controls=\"glossary-content-0\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Accepts healthy volunteers</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-0\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates whether people who do not have the <span class=\"term\" data-term=\"condition/disease\" tabindex=\"-1\" title=\"Show definition\">condition/disease</span> being studied can participate in that clinical study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-1\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Active comparator arm</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-1\" style=\"display: none;\">An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> considered to be effective (or active) by health care providers.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-2\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Adverse event</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-2\" style=\"display: none;\">An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of time after the study has ended. This change may or may not be caused by the <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> being studied.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-3\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Age or age group</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-3\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups:<p>The age groups are: </p><ul><li>Child (birth-17)</li><li>Adult (18-64)</li><li style=\"margin-bottom:-.4em;\">Older Adult (65+)</li></ul></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-4\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">All-cause mortality</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-4\" style=\"display: none;\">A measure of all deaths, due to any cause, that occur during a clinical study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-5\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Allocation</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-5\" style=\"display: none;\">A method used to assign participants to an arm of a clinical study. The types of allocation are <span class=\"term\" data-term=\"randomized allocation\" tabindex=\"-1\" title=\"Show definition\">randomized allocation</span> and nonrandomized.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-6\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Arm</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-6\" style=\"display: none;\">A group or subgroup of participants in a clinical trial that receives a specific <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span>, or no intervention, according to the trial's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-7\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Arm type</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-7\" style=\"display: none;\">A general description of the clinical trial arm. It identifies the role of the intervention that participants receive. Types of arms include <span class=\"term\" data-term=\"experimental arm\" tabindex=\"-1\" title=\"Show definition\">experimental arm</span>, <span class=\"term\" data-term=\"active comparator arm\" tabindex=\"-1\" title=\"Show definition\">active comparator arm</span>, <span class=\"term\" data-term=\"placebo comparator arm\" tabindex=\"-1\" title=\"Show definition\">placebo comparator arm</span>, <span class=\"term\" data-term=\"sham comparator arm\" tabindex=\"-1\" title=\"Show definition\">sham comparator arm</span>, and <span class=\"term\" data-term=\"no intervention arm\" tabindex=\"-1\" title=\"Show definition\">no intervention arm</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-8\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Baseline characteristics</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-8\" style=\"display: none;\">Data collected at the beginning of a clinical study for all participants and for each arm or comparison group. These data include demographics, such as age, sex/gender, race and ethnicity, and study-specific measures (for example, systolic blood pressure, prior antidepressant treatment).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-9\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Canceled submission</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-9\" style=\"display: none;\">Indicates that the study sponsor or investigator recalled a submission of <span class=\"term\" data-term=\"study results\" tabindex=\"-1\" title=\"Show definition\">study results</span> before <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> took place. If the submission was canceled on or after May 8, 2018, the date is shown. After submission of study results, a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> cannot be modified until QC review is completed, unless the submission is canceled.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-10\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Certain agreements</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-10\" style=\"display: none;\">Information required by the <span class=\"term\" data-term=\"food and drug administration amendments act of 2007, section 801 (fdaaa 801)\" tabindex=\"-1\" title=\"Show definition\">Food and Drug Administration Amendments Act of 2007</span>. In general, this is a description of any agreement between the sponsor of a clinical study and the <span class=\"term\" data-term=\"principal investigator (pi)\" tabindex=\"-1\" title=\"Show definition\">principal investigator</span> (PI) that does not allow the PI to discuss the results of the study or publish the study results in a scientific or academic journal after the study is completed.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-11\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Certification</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-11\" style=\"display: none;\">A sponsor or investigator may submit a certification to delay submission of results information if they are applying for FDA approval of a new drug or device, or new use of an already approved drug or device. A sponsor or investigator who submits a certification can delay results submission up to 2 years after the <span class=\"term\" data-term=\"certification/extension first submitted\" tabindex=\"-1\" title=\"Show definition\">certification/extension first submitted</span> date, unless certain events occur sooner. See <a href=\"https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType\" style=\"text-decoration:underline dotted\" tabindex=\"-1\" target=\"_blank\">Delay Results Type</a> in the Results Data Element definitions for more information about this certification.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-12\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Certification/extension first posted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-12\" style=\"display: none;\">The date on which information about a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> to delay submission of results or an <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span> was first available on ClinicalTrials.gov. ClinicalTrials.gov does not indicate whether the submission was a certification or extension request. There is typically a delay between the date the study sponsor or investigator submitted the certification or extension request and the <span class=\"term\" data-term=\"first posted\" tabindex=\"-1\" title=\"Show definition\">first posted date</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-13\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Certification/extension first submitted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-13\" style=\"display: none;\">The date on which the study sponsor or investigator first submitted a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> or an <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span> to delay submission of results. A sponsor or investigator who submits a certification can delay results submission up to 2 years after this date, unless certain events occur sooner. There is typically a delay between the date the certification or extension request was submitted and the date the information is first available on ClinicalTrials.gov (<span class=\"term\" data-term=\"certification/extension first posted\" tabindex=\"-1\" title=\"Show definition\">certification/extension first posted</span>).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-14\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Certification/extension first submitted that met QC criteria</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-14\" style=\"display: none;\">The date on which the study sponsor or investigator first submitted a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> or an <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span> that is consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a certification or extension request one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria. Meeting QC criteria for an extension request does not mean that the National Institutes of Health (NIH) has determined that the request demonstrates good cause. The process for review and granting of extension requests by the NIH is being developed.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-15\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">City and distance</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-15\" style=\"display: none;\">In the search feature, the City field is used to find clinical studies with locations in a specific city. The Distance field is used to find studies with locations within the specified distance from a city in number of miles. For example, if you choose Illinois as the <span class=\"term\" data-term=\"state\" tabindex=\"-1\" title=\"Show definition\">state</span>, identifying \"Chicago\" as the city and \"100 miles\" as the distance will find all studies listing a location within 100 miles of Chicago.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-16\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Clinical study</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-16\" style=\"display: none;\">A research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: <span class=\"term\" data-term=\"interventional study (clinical trial)\" tabindex=\"-1\" title=\"Show definition\">interventional studies</span> (also called clinical trials) and <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational studies</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-17\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Clinical trial</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-17\" style=\"display: none;\">Another name for an <span class=\"term\" data-term=\"interventional study (clinical trial)\" tabindex=\"-1\" title=\"Show definition\">interventional study</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-18\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">ClinicalTrials.gov identifier (NCT number)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-18\" style=\"display: none;\">The unique identification code given to each clinical study upon <span class=\"term\" data-term=\"registration\" tabindex=\"-1\" title=\"Show definition\">registration</span> at ClinicalTrials.gov. The format is \"NCT\" followed by an 8-digit number (for example, NCT00000419).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-19\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Collaborator</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-19\" style=\"display: none;\">An organization other than the <span class=\"term\" data-term=\"sponsor\" tabindex=\"-1\" title=\"Show definition\">sponsor</span> that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-20\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Condition/disease</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-20\" style=\"display: none;\">The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-21\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Contact</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-21\" style=\"display: none;\">The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-22\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Country</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-22\" style=\"display: none;\">In the search feature, the Country field is used to find clinical studies with locations in a specific country. For example,  if you choose the United States, you can then narrow your search by selecting a <span class=\"term\" data-term=\"state\" tabindex=\"-1\" title=\"Show definition\">state</span> and identifying a <span class=\"term\" data-term=\"city and distance\" tabindex=\"-1\" title=\"Show definition\">city and distance</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-23\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Cross-over assignment</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-23\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which groups of participants receive two or more interventions in a specific order. For example, two-by-two cross-over assignment involves two groups of participants. One group receives drug A during the initial phase of the trial, followed by drug B during a later phase. The other group receives drug B during the initial phase, followed by drug A. So during the trial, participants \"cross over\" to the other drug. All participants receive drug A and drug B at some point during the trial but in a different order, depending on the group to which they are assigned.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-24\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Data Monitoring Committee (DMC)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-24\" style=\"display: none;\">A group of independent scientists who monitor the safety and scientific integrity of a <span class=\"term\" data-term=\"clinical trial\" tabindex=\"-1\" title=\"Show definition\">clinical trial</span>. The DMC can recommend to the sponsor that the trial be stopped if it is not effective, is harming participants, or is unlikely to serve its scientific purpose. Members are chosen based on the scientific skills and knowledge needed to monitor the particular trial. Also called a data safety and monitoring board, or DSMB.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-25\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Early Phase 1 (formerly listed as Phase 0)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-25\" style=\"display: none;\">A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research used to describe exploratory trials conducted before traditional <span class=\"term\" data-term=\"phase 1\" tabindex=\"-1\" title=\"Show definition\">phase 1</span> trials to investigate how or whether a drug affects the body. They involve very limited human exposure to the drug and have no therapeutic or diagnostic goals (for example, screening studies, microdose studies).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-26\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Eligibility criteria</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-26\" style=\"display: none;\">The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both <span class=\"term\" data-term=\"inclusion criteria\" tabindex=\"-1\" title=\"Show definition\">inclusion criteria</span> (which are required for a person to participate in the study) and <span class=\"term\" data-term=\"exclusion criteria\" tabindex=\"-1\" title=\"Show definition\">exclusion criteria</span> (which prevent a person from participating). Types of eligibility criteria include whether a study <span class=\"term\" data-term=\"accepts healthy volunteers\" tabindex=\"-1\" title=\"Show definition\"> accepts healthy volunteers</span>, has <span class=\"term\" data-term=\"age or age group\" tabindex=\"-1\" title=\"Show definition\">age or age group</span> requirements, or is limited by <span class=\"term\" data-term=\"sex\" tabindex=\"-1\" title=\"Show definition\">sex</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-27\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Enrollment</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-27\" style=\"display: none;\">The number of participants in a clinical study. The \"estimated\" enrollment is the target number of participants that the researchers need for the study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-28\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Exclusion criteria</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-28\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span>. These are reasons that a person is not allowed to participate in a clinical study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-29\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Expanded access</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-29\" style=\"display: none;\">A way for patients with serious diseases or conditions who cannot participate in a clinical trial to gain access to a medical product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">U.S. Food and Drug Administration (FDA)</span>. Also called compassionate use.  There are different <span class=\"term\" data-term=\"expanded access type\" tabindex=\"-1\" title=\"Show definition\">expanded access types</span>. <p style=\"margin-bottom:-.4em;\">For more information, see FDA <a href=\"https://www.fda.gov/news-events/public-health-focus/expanded-access\" style=\"text-decoration:underline dotted\" tabindex=\"-1\" target=\"_blank\">Expanded Access: Information for Patients</a>.</p></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-30\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Expanded access status</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-30\" style=\"display: none;\"><ul><li><strong>Available:</strong> <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">Expanded access</span> is currently available for this investigational treatment, and patients who are not participants in the clinical study may be able to gain access to the drug, biologic, or medical device being studied.</li><li><strong>No longer available:</strong> <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">Expanded access</span> was available for this intervention previously but is not currently available and will not be available in the future.</li><li><strong>Temporarily not available:</strong> <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">Expanded access</span> is not currently available for this intervention but is expected to be available in the future.</li><li><strong>Approved for marketing:</strong> The intervention has been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\"> U.S. Food and Drug Administration</span> for use by the public.</li></ul></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-31\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Expanded access type</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-31\" style=\"display: none;\">Describes the category of <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">expanded access</span> under <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">U.S. Food and Drug Administration (FDA)</span> regulations. There are three types of expanded access: <ul><li><strong>Individual Patients</strong>: Allows a single patient, with a serious disease or condition who cannot participate in a clinical trial, access to a drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>. This category also includes access in an emergency situation.</li><li><strong>Intermediate-size Population</strong>: Allows more than one patient (but generally fewer patients than through a Treatment IND/Protocol) access to a drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>.  This type of expanded access is used when multiple patients with the same disease or condition seek access to a specific drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>.</li><li><strong><a id=\"treatment-ind\" tabindex=\"-1\"></a>Treatment IND/Protocol</strong>: Allows a large, widespread population access to a drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>. This type of expanded access can only be provided if the product is already being developed for marketing for the same use as the expanded access use.</li></ul></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-32\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Experimental arm</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-32\" style=\"display: none;\">An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives the <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> that is the focus of the clinical trial.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-33\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Extension request</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-33\" style=\"display: none;\">In certain circumstances, a sponsor or investigator may request an extension to delay the standard results submission deadline (generally one year after the <span class=\"term\" data-term=\"primary completion date\" tabindex=\"-1\" title=\"Show definition\">primary completion date</span>). The request for an extension must demonstrate good cause (for example, the need to preserve the scientific integrity of an ongoing <span class=\"term\" data-term=\"masking\" tabindex=\"-1\" title=\"Show definition\">masked</span> trial). All requests must be reviewed and granted by the National Institutes of Health. This process for review and granting of extension requests is being developed. See <a href=\"https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType\" style=\"text-decoration:underline dotted\" tabindex=\"-1\" target=\"_blank\">Delay Results Type</a> in the Results Data Element definitions for more information.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-34\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Factorial assignment</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-34\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which groups of participants receive one of several combinations of interventions. For example, two-by-two factorial assignment involves four groups of participants. Each group receives one of the following pairs of interventions: (1) drug A and drug B, (2) drug A and a placebo, (3) a placebo and drug B, or (4) a placebo and a placebo. So during the trial, all possible combinations of the two drugs (A and B) and the placebos are given to different groups of participants.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-35\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">FDAAA 801 Violations</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-35\" style=\"display: none;\">A FDAAA 801 Violation is shown on a study record when the U.S. Food and Drug Administration (FDA) has issued a Notice of Noncompliance to the responsible party of an applicable clinical trial. A Notice of Noncompliance indicates that the FDA has determined the responsible party was not in compliance with the registration or results reporting requirements for the clinical trial under the Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801).<p>The National Library of Medicine (NLM) is required by FDAAA 801 to add information to a study record about any FDAAA 801 Violation. This information is provided by the FDA. There are three categories of information that may be included:</p><ul><li>Violation: Shown when the FDA issues a Notice of Noncompliance and posts the Notice of Noncompliance on its designated webpage. There are three types of violations:<ul><li>Failure to submit required clinical trial information</li><li>Submission of false or misleading clinical trial information</li><li>Failure to submit primary and secondary outcomes</li></ul></li><li>Correction: Shown when the FDA confirms that the responsible party has updated the study record to correct the violation and posts the correction notice on its designated webpage.  Because of the time for FDA review and processing, there may be a delay between the date when the study record was updated and the addition of correction information to the FDAAA 801 Violation information. </li><li>Penalty: Shown when the FDA imposes a penalty for the violation and posts the penalty notice on its designated webpage.</li></ul></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-36\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">First posted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-36\" style=\"display: none;\">The date on which the <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> was first available on ClinicalTrials.gov. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-37\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">First submitted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-37\" style=\"display: none;\">The date on which the study sponsor or investigator first submitted a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the <span class=\"term\" data-term=\"first posted\" tabindex=\"-1\" title=\"Show definition\">first posted</span> date).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-38\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">First submitted that met QC criteria</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-38\" style=\"display: none;\">The date on which the study sponsor or investigator first submits a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> that is consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-39\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-39\" style=\"display: none;\">U.S. Public Law 110-85, which was enacted on September 27, 2007. Section 801 of FDAAA amends Section 402 of the U.S. Public Health Service Act to expand ClinicalTrials.gov and create a clinical study <span class=\"term\" data-term=\"results database\" tabindex=\"-1\" title=\"Show definition\">results database</span>. For more information on FDAAA 801, see the <a href=\"https://clinicaltrials.gov/ct2/about-site/history\" style=\"text-decoration:underline dotted\" tabindex=\"-1\" target=\"_blank\">History, Policies, and Laws</a> page on this site.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-40\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Funder type</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-40\" style=\"display: none;\">Describes the organization that provides funding or support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting. Organizations listed as <span class=\"term\" data-term=\"sponsor\" tabindex=\"-1\" title=\"Show definition\">sponsors</span> and <span class=\"term\" data-term=\"collaborator\" tabindex=\"-1\" title=\"Show definition\">collaborators</span> for a study are considered the funders of the study. ClinicalTrials.gov refers to four types of funders: <ul><li>U.S. National Institutes of Health</li><li>Other U.S. Federal agencies (for example, Food and Drug Administration, Centers for Disease Control and Prevention, or U.S. Department of Veterans Affairs)</li><li>Industry (for example: pharmaceutical and device companies)</li><li>All others (including individuals, universities, and community-based organizations)</li></ul></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-41\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Gender-based eligibility</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-41\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates whether eligibility to participate in a clinical study is based a person's self-representation of gender identity or gender (yes, no). Gender is distinct from <span class=\"term\" data-term=\"sex\" tabindex=\"-1\" title=\"Show definition\">sex</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-42\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Group/cohort</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-42\" style=\"display: none;\">A group or subgroup of participants in an <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational study</span> that is assessed for biomedical or health outcomes.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-43\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Human subjects protection review board</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-43\" style=\"display: none;\">A group of people who review, approve, and monitor the clinical study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>. Their role is to protect the rights and welfare of people participating in a study (referred to as human research subjects), such as reviewing the <span class=\"term\" data-term=\"informed consent form (icf)\" tabindex=\"-1\" title=\"Show definition\">informed consent form</span>. The group typically includes people with varying backgrounds, including a community member, to make sure that research activities conducted by an organization are completely and adequately reviewed. Also called an institutional review board, or IRB, or an ethics committee.<p>For more information, see <a href=\"https://clinicaltrials.gov/ct2/about-studies/learn#Participating\" style=\"text-decoration:underline dotted\" tabindex=\"-1\" target=\"_blank\">Participating in Studies</a> on this site.</p></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-44\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Inclusion criteria</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-44\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span>. These are the reasons that a person is allowed to participate in a clinical study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-45\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Informed consent</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-45\" style=\"display: none;\">A process used by researchers to communicate to potential and enrolled participants the risks and potential benefits of participating in a clinical study. <p>For more information, see <a href=\"https://clinicaltrials.gov/ct2/about-studies/learn#Participating\" style=\"text-decoration:underline dotted\" tabindex=\"-1\" target=\"_blank\">Participating in Studies</a> on this site.</p></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-46\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Informed consent form (ICF)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-46\" style=\"display: none;\">The document used in the <span class=\"term\" data-term=\"informed consent\" tabindex=\"-1\" title=\"Show definition\">informed consent</span> or process.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-47\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Intervention model</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-47\" style=\"display: none;\">The general design of the strategy for assigning interventions to participants in a clinical study. Types of intervention models include: <span class=\"term\" data-term=\"single group assignment\" tabindex=\"-1\" title=\"Show definition\">single group assignment</span>, <span class=\"term\" data-term=\"parallel assignment\" tabindex=\"-1\" title=\"Show definition\">parallel assignment</span>, <span class=\"term\" data-term=\"cross-over assignment\" tabindex=\"-1\" title=\"Show definition\">cross-over assignment</span>, and <span class=\"term\" data-term=\"factorial assignment\" tabindex=\"-1\" title=\"Show definition\">factorial assignment</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-48\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Intervention/treatment</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-48\" style=\"display: none;\">A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-49\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Interventional study (clinical trial)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-49\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span> in which participants are assigned to groups that receive one or more <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. The assignments are determined by the study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>. Participants may receive diagnostic, therapeutic, or other types of interventions.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-50\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Investigator</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-50\" style=\"display: none;\">A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study <span class=\"term\" data-term=\"principal investigator (pi)\" tabindex=\"-1\" title=\"Show definition\">principal investigator</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-51\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Last update posted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-51\" style=\"display: none;\">The most recent date on which changes to a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the <span class=\"term\" data-term=\"last update submitted\" tabindex=\"-1\" title=\"Show definition\">last update submitted</span> date) and the last update posted date.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-52\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Last update submitted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-52\" style=\"display: none;\">The most recent date on which the study sponsor or investigator submitted changes to a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> to ClinicalTrials.gov. There is typically a delay of a few days between the last update submitted date and when the date changes are posted on ClinicalTrials.gov (the <span class=\"term\" data-term=\"last update posted\" tabindex=\"-1\" title=\"Show definition\">last update posted</span> date).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-53\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Last update submitted that met QC criteria</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-53\" style=\"display: none;\">The most recent date on which the study sponsor or investigator submitted changes to a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> that are consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-54\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Last verified</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-54\" style=\"display: none;\">The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span> of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span> is shown as <span class=\"term\" data-term=\"unknown\" tabindex=\"-1\" title=\"Show definition\">unknown</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-55\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Listed location countries</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-55\" style=\"display: none;\">Countries in which research facilities for a study are located. A country is listed only once, even if there is more than one facility in the country. The list includes all countries as of the <span class=\"term\" data-term=\"last update submitted\" tabindex=\"-1\" title=\"Show definition\">last update submitted</span> date; any country for which all facilities were removed from the <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> are listed under <span class=\"term\" data-term=\"removed location countries\" tabindex=\"-1\" title=\"Show definition\">removed location countries</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-56\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Location terms</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-56\" style=\"display: none;\">In the search feature, the Location terms field is used to narrow a search by location-related terms other than Country, State, and City or distance. For example, you may enter a specific facility name (such as National Institutes of Health Clinical Center) or a part of a facility name (such as Veteran for studies listing Veterans Hospital or Veteran Affairs in the facility name). Note: Not all <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study records</span> include this level of detail about locations.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-57\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Masking</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-57\" style=\"display: none;\">A clinical trial design strategy in which one or more parties involved in the trial, such as the investigator or participants, do not know which participants have been assigned which interventions. Types of masking include: open label, single blind masking, and double-blind masking.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-58\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">NCT number</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-58\" style=\"display: none;\">A unique identification code given to each clinical study record registered on ClinicalTrials.gov. The format is \"NCT\" followed by an 8-digit number (for example, NCT00000419). Also called the <span class=\"term\" data-term=\"clinicaltrials.gov identifier (nct number)\" tabindex=\"-1\" title=\"Show definition\">ClinicalTrials.gov identifier</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-59\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">No intervention arm</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-59\" style=\"display: none;\">An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants does not receive any <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> during the clinical trial.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-60\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Observational study</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-60\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span> in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to a specific <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">interventions/treatment</span>.<p>A <span class=\"term\" data-term=\"patient registry\" tabindex=\"-1\" title=\"Show definition\">patient registry</span> is a type of observational study.</p></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-61\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Observational study model</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-61\" style=\"display: none;\">The general design of the strategy for identifying and following up with participants during an <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational study</span>. Types of observational study models include cohort, case-control, case-only, case-cross-over, ecologic or community studies, family-based, and other.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-62\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Other adverse event</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-62\" style=\"display: none;\">An <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse event</span> that is not a <span class=\"term\" data-term=\"serious adverse event\" tabindex=\"-1\" title=\"Show definition\">serious adverse event</span>, meaning that it does not result in death, is not life-threatening, does not require inpatient hospitalization or extend a current hospital stay, does not result in an ongoing or significant incapacity or interfere substantially with normal life functions, and does not cause a congenital anomaly or birth defect; it also does not put the participant in danger and does not require medical or surgical intervention to prevent one of the results listed above.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-63\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Other study IDs</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-63\" style=\"display: none;\">Identifiers or ID numbers other than the <span class=\"term\" data-term=\"nct number\" tabindex=\"-1\" title=\"Show definition\">NCT number</span> that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-64\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Other terms</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-64\" style=\"display: none;\">In the search feature, the Other terms field is used to narrow a search. For example, you may enter the name of a drug or the NCT number of a clinical study to limit the search to <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study records</span> that contain these words.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-65\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Outcome measure</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-65\" style=\"display: none;\">For <span class=\"term\" data-term=\"clinical trial\" tabindex=\"-1\" title=\"Show definition\">clinical trials</span>, a planned measurement described in the protocol that is used to determine the effect of an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> on participants. For <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational studies</span>, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include <span class=\"term\" data-term=\"primary outcome measure\" tabindex=\"-1\" title=\"Show definition\">primary outcome measure</span> and <span class=\"term\" data-term=\"secondary outcome measure\" tabindex=\"-1\" title=\"Show definition\">secondary outcome measure</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-66\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Parallel assignment</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-66\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which two or more groups of participants receive different interventions. For example, a two-arm parallel assignment involves two groups of participants. One group receives drug A, and the other group receives drug B. So during the trial, participants in one group receive drug A \"in parallel\" to participants in the other group, who receive drug B.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-67\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Participant flow</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-67\" style=\"display: none;\">A summary of the progress of participants through each stage of a clinical study, by study <span class=\"term\" data-term=\"arm\" tabindex=\"-1\" title=\"Show definition\">arm</span> or <span class=\"term\" data-term=\"group/cohort\" tabindex=\"-1\" title=\"Show definition\">group/cohort</span>. This includes the number of participants who started, completed, and dropped out of the study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-68\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Patient registry</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-68\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational study</span> that collects information about patients' medical conditions and/or treatments to better understand how a condition or treatment affects patients in the real world.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-69\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Phase</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-69\" style=\"display: none;\">The stage of a clinical trial studying a drug or biological product, based on definitions developed by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">U.S. Food and Drug Administration (FDA)</span>. The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: <span class=\"term\" data-term=\"early phase 1 (formerly listed as phase 0)\" tabindex=\"-1\" title=\"Show definition\">Early Phase 1 (formerly listed as Phase 0)</span>, <span class=\"term\" data-term=\"phase 1\" tabindex=\"-1\" title=\"Show definition\">Phase 1</span>, <span class=\"term\" data-term=\"phase 2\" tabindex=\"-1\" title=\"Show definition\">Phase 2</span>, <span class=\"term\" data-term=\"phase 3\" tabindex=\"-1\" title=\"Show definition\">Phase 3</span>, and <span class=\"term\" data-term=\"phase 4\" tabindex=\"-1\" title=\"Show definition\">Phase 4</span>. <span class=\"term\" data-term=\"phase not applicable\" tabindex=\"-1\" title=\"Show definition\">Not Applicable</span> is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-70\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Phase 1</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-70\" style=\"display: none;\">A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials that focus on the safety of a drug. They are usually conducted with healthy volunteers, and the goal is to determine the drug's most frequent and <span class=\"term\" data-term=\"serious adverse event\" tabindex=\"-1\" title=\"Show definition\">serious adverse events</span> and, often, how the drug is broken down and excreted by the body. These trials usually involve a small number of participants.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-71\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Phase 2</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-71\" style=\"display: none;\">A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials that gather preliminary data on whether a drug works in people who have a certain <span class=\"term\" data-term=\"condition/disease\" tabindex=\"-1\" title=\"Show definition\">condition/disease</span> (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a <span class=\"term\" data-term=\"placebo\" tabindex=\"-1\" title=\"Show definition\">placebo</span>) or a different drug. Safety continues to be evaluated, and short-term <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse events</span> are studied.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-72\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Phase 3</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-72\" style=\"display: none;\">A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-73\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Phase 4</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-73\" style=\"display: none;\">A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials occurring after FDA has approved a drug for marketing. They include postmarket requirement and commitment studies that are required of or agreed to by the study sponsor. These trials gather additional information about a drug's safety, efficacy, or optimal use.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-74\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Phase Not Applicable</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-74\" style=\"display: none;\">Describes trials without FDA-defined <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phases</span>, including trials of devices or behavioral interventions.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-75\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Placebo</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-75\" style=\"display: none;\">An inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> being studied.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-76\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Placebo comparator arm</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-76\" style=\"display: none;\">An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives a <span class=\"term\" data-term=\"placebo\" tabindex=\"-1\" title=\"Show definition\">placebo</span> during a clinical trial.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-77\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Primary completion date</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-77\" style=\"display: none;\">The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the <span class=\"term\" data-term=\"primary outcome measure\" tabindex=\"-1\" title=\"Show definition\">primary outcome measure</span>. Whether the clinical study ended according to the <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span> or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The \"estimated\" primary completion date is the date that the researchers think will be the primary completion date for the study. </div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-78\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Primary outcome measure</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-78\" style=\"display: none;\">In a clinical study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, the planned outcome measure that is the most important for evaluating the effect of an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span>. Most clinical studies have one primary outcome measure, but some have more than one.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-79\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Primary purpose</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-79\" style=\"display: none;\">The main reason for the <span class=\"term\" data-term=\"clinical trial\" tabindex=\"-1\" title=\"Show definition\">clinical trial</span>. The types of primary purpose are: treatment, prevention, diagnostic, supportive care, screening, health services research, basic science, and other.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-80\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Principal investigator (PI)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-80\" style=\"display: none;\">The person who is responsible for the scientific and technical direction of the entire clinical study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-81\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Protocol</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-81\" style=\"display: none;\">The written description of a clinical study. It includes the study's objectives, design, and methods. It may also include relevant scientific background and statistical information.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-82\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Quality control (QC) review</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-82\" style=\"display: none;\">National Library of Medicine (NLM) staff perform a limited review of submitted <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study records</span> for apparent errors, deficiencies, or inconsistencies. NLM staff identify potential major and advisory issues and provide comments directly to the study sponsor or investigator. Major issues identified in QC review must be addressed or corrected (see <span class=\"term\" data-term=\"first submitted that met qc criteria\" tabindex=\"-1\" title=\"Show definition\">First submitted that met QC criteria</span> and <span class=\"term\" data-term=\"results first submitted that met qc criteria\" tabindex=\"-1\" title=\"Show definition\">Results first submitted that met QC criteria</span>). Advisory issues are suggestions to help improve the clarity of the record. NLM staff do not verify the scientific validity or relevance of the submitted information. The study sponsor or investigator is responsible for ensuring that the studies follow all applicable laws and regulations.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-83\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Randomized allocation</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-83\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"allocation\" tabindex=\"-1\" title=\"Show definition\">allocation</span> strategy in which participants are assigned to the <span class=\"term\" data-term=\"arm\" tabindex=\"-1\" title=\"Show definition\">arms</span> of a clinical trial by chance.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-84\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Recruitment status</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-84\" style=\"display: none;\"><ul><li><strong>Not yet recruiting:</strong> The study has not started recruiting participants.</li><li><strong>Recruiting:</strong> The study is currently recruiting participants.</li><li><strong>Enrolling by invitation:</strong> The study is selecting its participants from a population, or group of people, decided on by the researchers in advance. These studies are not open to everyone who meets the eligibility criteria but only to people in that particular population, who are specifically invited to participate.</li><li><strong>Active, not recruiting:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but potential participants are not currently being recruited or enrolled.</li><li><strong>Suspended:</strong> The study has stopped early but may start again.</li><li><strong>Terminated:</strong> The study has stopped early and will not start again. Participants are no longer being examined or treated.</li><li><strong>Completed:</strong> The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).</li><li><strong>Withdrawn:</strong> The study stopped early, before enrolling its first participant.</li><li><strong>Unknown:</strong> A study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been <span class=\"term\" data-term=\"last verified\" tabindex=\"-1\" title=\"Show definition\">last verified</span> within the past 2 years.</li></ul></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-85\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Registration</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-85\" style=\"display: none;\">The process of submitting and updating summary information about a clinical study and its <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, from its beginning to end, to a structured, public Web-based <span class=\"term\" data-term=\"study registry\" tabindex=\"-1\" title=\"Show definition\">study registry</span> that is accessible to the public, such as ClinicalTrials.gov.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-86\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Removed location countries</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-86\" style=\"display: none;\">Countries that appeared under <span class=\"term\" data-term=\"listed location countries\" tabindex=\"-1\" title=\"Show definition\">listed location countries</span> but were removed from the <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> by the sponsor or investigator.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-87\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Reporting group</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-87\" style=\"display: none;\">A grouping of participants in a clinical study that is used for summarizing the data collected during the study. This grouping may be the same as or different from a study arm or group.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-88\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Responsible party</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-88\" style=\"display: none;\">The person responsible for submitting information about a clinical study to ClinicalTrials.gov and updating that information. Usually the study sponsor or investigator.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-89\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Results database</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-89\" style=\"display: none;\">A structured online system, such as the ClinicalTrials.gov results database, that provides the public with access to registration and summary results information for completed or terminated clinical studies. A study with results available on ClinicalTrials.gov is described as having the results \"posted.\" <p><strong>Note:</strong> The ClinicalTrials.gov results database became available in September 2008. Older studies are unlikely to have results available in the database.</p></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-90\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Results delayed</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-90\" style=\"display: none;\">Indicates that the sponsor or investigator submitted a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> or <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-91\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Results first posted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-91\" style=\"display: none;\">The date on which summary results information was first available on ClinicalTrials.gov. There is typically a delay between the date the study sponsor or investigator first submits summary results information (the <span class=\"term\" data-term=\"results first submitted\" tabindex=\"-1\" title=\"Show definition\">results first submitted</span> date) and the results first posted date.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-92\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Results first submitted</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-92\" style=\"display: none;\">The date on which the study sponsor or investigator first submits a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> with summary results information. There is typically a delay between the results first submitted date and when summary results information becomes available on ClinicalTrials.gov (the <span class=\"term\" data-term=\"results first posted\" tabindex=\"-1\" title=\"Show definition\">results first posted</span> date).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-93\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Results first submitted that met QC criteria</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-93\" style=\"display: none;\">The date on which the study sponsor or investigator first submits a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> with summary results information that is consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit results information one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-94\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Results returned after quality control review</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-94\" style=\"display: none;\">The date on which the National Library of Medicine provided <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> comments to the study sponsor or investigator. The sponsor or investigator must address major issues identified in the review comments. If there is a date listed for results returned after quality control review, but there is not a subsequent date listed for <span class=\"term\" data-term=\"results submitted to clinicaltrials.gov\" tabindex=\"-1\" title=\"Show definition\">results submitted to ClinicalTrials.gov</span>, this means that the submission is pending changes by the sponsor or investigator.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-95\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Results submitted to ClinicalTrials.gov</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-95\" style=\"display: none;\">Indicates that the study sponsor or investigator has submitted summary results information for a clinical study to ClinicalTrials.gov but the <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> process has not concluded.<p>The results submitted date indicates when the study sponsor or investigator first submitted summary results information or submitted changes to summary results information. Submissions with changes are typically in response to  QC review comments from the National Library of Medicine (NLM). If there is a date listed for results submitted to ClinicalTrials.gov, but there is not a subsequent date listed for <span class=\"term\" data-term=\"results returned after quality control review\" tabindex=\"-1\" title=\"Show definition\">results returned after quality control review</span>, this means that the submission is pending review by NLM.</p></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-96\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Secondary outcome measure</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-96\" style=\"display: none;\">In a clinical study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-97\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Serious adverse event</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-97\" style=\"display: none;\">An <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse event</span> that results in death, is life-threatening, requires inpatient hospitalization or extends a current hospital stay, results in an ongoing or significant incapacity or interferes substantially with normal life functions, or causes a congenital anomaly or birth defect. Medical events that do not result in death, are not life-threatening, or do not require hospitalization may be considered serious adverse events if they put the participant in danger or require medical or surgical intervention to prevent one of the results listed above.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-98\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Sex</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-98\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates the sex of people who may participate in a clinical study (all, female, male). Sex is a person's classification as female or male based on biological distinctions. Sex is distinct from <span class=\"term\" data-term=\"gender-based eligibility\" tabindex=\"-1\" title=\"Show definition\">gender-based eligibility</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-99\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Sham comparator arm</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-99\" style=\"display: none;\">An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives a procedure or device that appears to be the same as the actual procedure or device being studied but does not contain active processes or components.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-100\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Single group assignment</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-100\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which all participants receive the same intervention/treatment.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-101\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Sort studies by</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-101\" style=\"display: none;\">In Advanced Search, the Sort studies by option is used to change the order of studies listed on the Search Results page. You can sort by Relevance or Newest First: <ul><li>Relevance: Studies that best match your search terms appear higher in the search results list. This is the default display for all searches.</li><li>Newest First: Studies with the most recent <span class=\"term\" data-term=\"first posted\" tabindex=\"-1\" title=\"Show definition\">First posted</span> dates appear higher in the search results list.</li></ul></div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-102\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Sponsor</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-102\" style=\"display: none;\">The organization or person who initiates the study and who has authority and control over the study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-103\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">State</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-103\" style=\"display: none;\">In the search feature, the State field is used to find clinical studies with locations in a specific state within the United States. If you choose United States in the <span class=\"term\" data-term=\"country\" tabindex=\"-1\" title=\"Show definition\">Country</span> field, you can search for studies with locations in a specific state.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-104\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Statistical analysis plan (SAP)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-104\" style=\"display: none;\">The written description of the statistical considerations and methods for analyzing the data collected in the <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-105\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Status</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-105\" style=\"display: none;\">Indicates the current <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span> or the <span class=\"term\" data-term=\"expanded access status\" tabindex=\"-1\" title=\"Show definition\">expanded access status</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-106\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study completion date</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-106\" style=\"display: none;\">The date on which the last participant in a clinical study was examined or received an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> to collect final data for the <span class=\"term\" data-term=\"primary outcome measure\" tabindex=\"-1\" title=\"Show definition\">primary outcome measures</span>, <span class=\"term\" data-term=\"secondary outcome measure\" tabindex=\"-1\" title=\"Show definition\">secondary outcome measures</span>, and <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse events</span> (that is, the last participant's last visit). The \"estimated\" study completion date is the date that the researchers think will be the study completion date.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-107\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study design</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-107\" style=\"display: none;\">The investigative methods and strategies used in the clinical study.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-108\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study documents</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-108\" style=\"display: none;\">Refers to the type of documents that the study sponsor or principal investigator may add to their <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span>. These include a study <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, <span class=\"term\" data-term=\"statistical analysis plan (sap)\" tabindex=\"-1\" title=\"Show definition\">statistical analysis plan</span>, and <span class=\"term\" data-term=\"informed consent form (icf)\" tabindex=\"-1\" title=\"Show definition\">informed consent form</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-109\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study IDs</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-109\" style=\"display: none;\">Identifiers that are assigned to a clinical study by the study's <span class=\"term\" data-term=\"sponsor\" tabindex=\"-1\" title=\"Show definition\">sponsor</span>, funders, or others. They include unique identifiers from other trial <span class=\"term\" data-term=\"study registry\" tabindex=\"-1\" title=\"Show definition\">study registries</span> and National Institutes of Health grant numbers. Note: ClinicalTrials.gov assigns a unique identification code to each clinical study registered on ClinicalTrials.gov. Also called the <span class=\"term\" data-term=\"nct number\" tabindex=\"-1\" title=\"Show definition\">NCT number</span>, the format is \"NCT\" followed by an 8-digit number (for example, NCT00000419).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-110\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study record</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-110\" style=\"display: none;\">An entry on ClinicalTrials.gov that contains a summary of a clinical study's protocol information, including the <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span>; eligibility criteria; contact information; and, in some cases, summary results. Each study record is assigned a ClinicalTrials.gov identifier, or <span class=\"term\" data-term=\"nct number\" tabindex=\"-1\" title=\"Show definition\">NCT number</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-111\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study registry</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-111\" style=\"display: none;\">A structured online system, such as ClinicalTrials.gov, that provides the public with access to summary information about ongoing and completed clinical studies.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-112\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study results</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-112\" style=\"display: none;\">A <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> that includes the summary results posted in the ClinicalTrials.gov <span class=\"term\" data-term=\"results database\" tabindex=\"-1\" title=\"Show definition\">results database</span>. Summary results information includes <span class=\"term\" data-term=\"participant flow\" tabindex=\"-1\" title=\"Show definition\">participant flow</span>, <span class=\"term\" data-term=\"baseline characteristics\" tabindex=\"-1\" title=\"Show definition\">baseline characteristics</span>, <span class=\"term\" data-term=\"outcome measure\" tabindex=\"-1\" title=\"Show definition\">outcome measures</span>, and <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse events</span> (including <span class=\"term\" data-term=\"serious adverse event\" tabindex=\"-1\" title=\"Show definition\">serious adverse events</span>).</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-113\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study start date</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-113\" style=\"display: none;\">The actual date on which the first participant was enrolled in a clinical study. The \"estimated\" study start date is the date that the researchers think will be the study start date.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-114\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Study type</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-114\" style=\"display: none;\">Describes the nature of a <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span>. Study types include <span class=\"term\" data-term=\"interventional study (clinical trial)\" tabindex=\"-1\" title=\"Show definition\">interventional studies</span> (also called clinical trials), <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational studies</span> (including <span class=\"term\" data-term=\"patient registry\" tabindex=\"-1\" title=\"Show definition\">patient registries</span>), and <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">expanded access</span>.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-115\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Submitted date</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-115\" style=\"display: none;\">The date on which the study sponsor or investigator submitted a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-116\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Title</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-116\" style=\"display: none;\">The official title of a <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span> used to identify a clinical study or a short title written in language intended for the lay public.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-117\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Title acronym</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-117\" style=\"display: none;\">The acronym or initials used to identify a clinical study (not all studies have one). For example, the title acronym for the Women's Health Initiative is \"WHI.\"</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-118\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">U.S. Agency for Healthcare Research and Quality (AHRQ)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-118\" style=\"display: none;\">An agency within the U.S. Department of Health and Human Services. AHRQ's mission is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-119\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">U.S. Food and Drug Administration (FDA)</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-119\" style=\"display: none;\">An agency within the U.S. Department of Health and Human Services. The FDA is responsible for protecting the public health by making sure that human and veterinary drugs, vaccines and other biological products, medical devices, the Nation's food supply, cosmetics, dietary supplements, and products that give off radiation are safe, effective, and secure.</div></li><li class=\"glossary__item\"><button aria-controls=\"glossary-content-120\" aria-expanded=\"false\" class=\"data-glossary-term glossary__term\" tabindex=\"-1\">Unknown</button><div aria-hidden=\"true\" class=\"glossary__definition\" id=\"glossary-content-120\" style=\"display: none;\">A type of <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span>. It identifies a study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been verified within the past 2 years. Studies with an unknown status are considered closed studies.</div></li></ul>\n",
       "</div>\n",
       "</div>\n",
       "<div id=\"skip\"> <a href=\"#body-copy\">Skip to Main Content</a> </div>\n",
       "<script src=\"/ct2/html/js/working.js\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "<div class=\"ct-dim\" id=\"workingDim\">\n",
       "<div class=\"ct-workingBox\" id=\"workingIndicator\" style=\"text-align:center;vertical-align:middle;\">\n",
       "<img alt=\"Workingâ¦\" height=\"50\" src=\"/ct2/html/images/working.gif\"/>\n",
       "</div>\n",
       "</div>\n",
       "<div id=\"wrapper\">\n",
       "<div class=\"ct-inner_wrapper\"> <a href=\"/ct2/home\" style=\"float:left;border-bottom-width:0;min-width:200px;width:29%;\"><img alt=\"ClinicalTrials.gov\" src=\"/ct2/html/images/ct.gov-nlm-nih-logo.png\"/></a>\n",
       "<div class=\"w3-hide-medium w3-hide-large\" id=\"hamburger\" style=\"float:right;border-width:0;display:block;margin-left:1em;padding:4px;\" title=\"Show menus\">\n",
       "<img alt=\"ClinicalTrials.gov Menu\" onclick=\"$('#global-nav-popupMenu').toggle();\" src=\"/ct2/html/images/hamburgerMenuIcon.png\" style=\"max-width:30px;cursor:pointer;\"/>\n",
       "</div>\n",
       "<div class=\"w3-hide-medium w3-hide-large w3-modal w3-center\" id=\"global-nav-popupMenu\" onclick=\"$('#global-nav-popupMenu').hide();\" style=\"display:none;\"> <div class=\"w3-modal-content\" id=\"global-nav-popupMenu-content\">\n",
       "<div class=\"w3-container\">\n",
       "<span class=\"w3-closebtn\" onclick=\"$('#global-nav-popupMenu').hide();\">Ã</span>\n",
       "<ul class=\"sf-menu sf-vertical sf-js-enabled\">\n",
       "<li class=\"first\"><a class=\"sf-with-ul\" href=\"/ct2/search/index\">Find Studies<img alt=\"Find Studies Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/home\">New Search</a></li>\n",
       "<li><a href=\"/ct2/search/advanced\">Advanced Search</a></li>\n",
       "<li><a href=\"/ct2/search/browse?brwse=cond_cat\">See Studies by Topic</a></li>\n",
       "<li><a href=\"/ct2/search/map\">See Studies on Map</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/help/how-find/index\">How to Search</a></li>\n",
       "<li><a href=\"/ct2/help/how-use-search-results\">How to Use Search Results</a></li>\n",
       "<li><a href=\"/ct2/help/how-find/find-study-results\">How to Find Results of Studies</a></li>\n",
       "<li><a href=\"/ct2/help/how-read-study\">How to Read a Study Record</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a class=\"sf-with-ul\" href=\"/ct2/about-studies\">About Studies<img alt=\"About Studies Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/about-studies/learn\">Learn About Studies</a></li>\n",
       "<li><a href=\"/ct2/about-studies/other-sites\">Other Sites About Studies</a></li>\n",
       "<li><a href=\"/ct2/about-studies/glossary\">Glossary of Common Site Terms</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a class=\"sf-with-ul\" href=\"/ct2/manage-recs\">Submit Studies<img alt=\"Submit Studies Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/manage-recs/submit-study\">Submit Studies to ClinicalTrials.gov PRS</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/background\">Why Should I Register and Submit Results?</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/fdaaa\">FDAAA 801 and the Final Rule</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/manage-recs/how-apply\">How to Apply for a PRS Account</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/how-register\">How to Register Your Study</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/how-edit\">How to Edit Your Study Record</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/how-report\">How to Submit Your Results</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/manage-recs/faq\">Frequently Asked Questions</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/resources\">Support Materials</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/present\">Training Materials</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a class=\"sf-with-ul\" href=\"/ct2/resources\">Resources<img alt=\"Resources Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/resources/pubs\">Selected Publications</a></li>\n",
       "<li><a href=\"/ct2/resources/alert\">Clinical Alerts and Advisories</a></li>\n",
       "<li><a href=\"/ct2/resources/rss\">RSS Feeds</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/resources/trends\">Trends, Charts, and Maps</a></li>\n",
       "<li><a href=\"/ct2/resources/download\">Downloading Content for Analysis</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li class=\"last\"><a class=\"sf-with-ul\" href=\"/ct2/about-site\">About Site<img alt=\"About Site Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li class=\"new-group\"><a href=\"/ct2/about-site/new\">What's New</a></li>\n",
       "<li><a href=\"/ct2/about-site/background\">ClinicalTrials.gov Background</a></li>\n",
       "<li><a href=\"/ct2/about-site/results\">About the Results Database</a></li>\n",
       "<li><a href=\"/ct2/about-site/history\">History, Policies, and Laws</a></li>\n",
       "<li><a href=\"/ct2/about-site/modernization\">ClinicalTrials.gov Modernization</a></li>\n",
       "<li><a href=\"/ct2/about-site/for-media\">Media/Press Resources</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/about-site/link-to\">Linking to This Site</a></li>\n",
       "<li><a href=\"/ct2/about-site/terms-conditions\">Terms and Conditions</a></li>\n",
       "<li><a href=\"/ct2/about-site/disclaimer\">Disclaimer</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a href=\"/ct2/manage-recs/register\" title=\"Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)\"><span style=\"border-bottom:1px solid;padding-bottom:1px;padding-right:0;\">PRS Login</span></a>\n",
       "</li>\n",
       "</ul>\n",
       "</div>\n",
       "</div>\n",
       "</div>\n",
       "<div class=\"w3-hide-small\" style=\"float:right;margin-top:1.5%;\">\n",
       "<ul class=\"sf-menu sf-vertical sf-js-enabled\">\n",
       "<li class=\"first\"><a class=\"sf-with-ul\" href=\"/ct2/search/index\">Find Studies<img alt=\"Find Studies Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/home\">New Search</a></li>\n",
       "<li><a href=\"/ct2/search/advanced\">Advanced Search</a></li>\n",
       "<li><a href=\"/ct2/search/browse?brwse=cond_cat\">See Studies by Topic</a></li>\n",
       "<li><a href=\"/ct2/search/map\">See Studies on Map</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/help/how-find/index\">How to Search</a></li>\n",
       "<li><a href=\"/ct2/help/how-use-search-results\">How to Use Search Results</a></li>\n",
       "<li><a href=\"/ct2/help/how-find/find-study-results\">How to Find Results of Studies</a></li>\n",
       "<li><a href=\"/ct2/help/how-read-study\">How to Read a Study Record</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a class=\"sf-with-ul\" href=\"/ct2/about-studies\">About Studies<img alt=\"About Studies Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/about-studies/learn\">Learn About Studies</a></li>\n",
       "<li><a href=\"/ct2/about-studies/other-sites\">Other Sites About Studies</a></li>\n",
       "<li><a href=\"/ct2/about-studies/glossary\">Glossary of Common Site Terms</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a class=\"sf-with-ul\" href=\"/ct2/manage-recs\">Submit Studies<img alt=\"Submit Studies Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/manage-recs/submit-study\">Submit Studies to ClinicalTrials.gov PRS</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/background\">Why Should I Register and Submit Results?</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/fdaaa\">FDAAA 801 and the Final Rule</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/manage-recs/how-apply\">How to Apply for a PRS Account</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/how-register\">How to Register Your Study</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/how-edit\">How to Edit Your Study Record</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/how-report\">How to Submit Your Results</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/manage-recs/faq\">Frequently Asked Questions</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/resources\">Support Materials</a></li>\n",
       "<li><a href=\"/ct2/manage-recs/present\">Training Materials</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a class=\"sf-with-ul\" href=\"/ct2/resources\">Resources<img alt=\"Resources Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li><a href=\"/ct2/resources/pubs\">Selected Publications</a></li>\n",
       "<li><a href=\"/ct2/resources/alert\">Clinical Alerts and Advisories</a></li>\n",
       "<li><a href=\"/ct2/resources/rss\">RSS Feeds</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/resources/trends\">Trends, Charts, and Maps</a></li>\n",
       "<li><a href=\"/ct2/resources/download\">Downloading Content for Analysis</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li class=\"last\"><a class=\"sf-with-ul\" href=\"/ct2/about-site\">About Site<img alt=\"About Site Menu\" src=\"/ct2/html/images/pulldown.png\"/></a>\n",
       "<ul style=\"display: none;\">\n",
       "<li class=\"new-group\"><a href=\"/ct2/about-site/new\">What's New</a></li>\n",
       "<li><a href=\"/ct2/about-site/background\">ClinicalTrials.gov Background</a></li>\n",
       "<li><a href=\"/ct2/about-site/results\">About the Results Database</a></li>\n",
       "<li><a href=\"/ct2/about-site/history\">History, Policies, and Laws</a></li>\n",
       "<li><a href=\"/ct2/about-site/modernization\">ClinicalTrials.gov Modernization</a></li>\n",
       "<li><a href=\"/ct2/about-site/for-media\">Media/Press Resources</a></li>\n",
       "<li class=\"new-group\"><a href=\"/ct2/about-site/link-to\">Linking to This Site</a></li>\n",
       "<li><a href=\"/ct2/about-site/terms-conditions\">Terms and Conditions</a></li>\n",
       "<li><a href=\"/ct2/about-site/disclaimer\">Disclaimer</a></li>\n",
       "</ul>\n",
       "</li>\n",
       "<li><a href=\"/ct2/manage-recs/register\" title=\"Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)\"><span style=\"border-bottom:1px solid;padding-bottom:1px;padding-right:0;\">PRS Login</span></a>\n",
       "</li>\n",
       "</ul>\n",
       "<div style=\"clear:both;\"></div>\n",
       "</div>\n",
       "<div style=\"clear:both;\"></div>\n",
       "</div>\n",
       "<div class=\"ct-outer_breadcrumb w3-container\">\n",
       "<div id=\"breadcrumb\">\n",
       "<ul class=\"ct-horz-list w3-left\">\n",
       "<li><a href=\"/ct2/home\">Home</a></li>\n",
       "<li><a href=\"/ct2/about-studies\">About Studies</a></li>\n",
       "<li>Glossary of Common Site Terms</li>\n",
       "</ul>\n",
       "<div class=\"w3-right\" id=\"savedStudies\">\n",
       "<div id=\"cart\" onclick=\"location.href=('/ct2/results'+cartToURL()); showWorking();\" style=\"cursor: pointer; display: none;\">\n",
       "<button class=\"ct-savedStudiesEnabled\" id=\"open-cart-link\" onclick=\"location.href=('/ct2/results'+cartToURL()); showWorking();\" title=\"Show previously saved studies.\" type=\"button\">Saved Studies (0)</button>\n",
       "</div>\n",
       "</div>\n",
       "<script src=\"/ct2/html/js/cart.js?v=44\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "</div>\n",
       "</div>\n",
       "<div class=\"ct-inner_content_wrapper\">\n",
       "<div id=\"body-copy\"></div>\n",
       "<h1>Glossary of Common Site Terms</h1>\n",
       "<p>This glossary will help you understand words and phrases frequently used on ClinicalTrials.gov. Many of these words are also used by clinical researchers and others in the same or a similar manner. But the definitions below are provided to explain content on ClinicalTrials.gov only. </p>\n",
       "<p> For help with medical terms, see the <a href=\"https://medlineplus.gov/encyclopedia.html\" onclick=\"openNewWindow('https://medlineplus.gov/encyclopedia.html'); return false\" title=\"MedlinePlus Medical Encyclopedia - opens new window\">MedlinePlusÂ® Medical Encyclopedia</a>. </p>\n",
       "<p> Study record managers should refer to the <a href=\"https://prsinfo.clinicaltrials.gov/definitions.html\" onclick=\"openNewWindow('https://prsinfo.clinicaltrials.gov/definitions.html'); return false\" title=\"Protocol Registration Data Element Definitions - opens new window\">Protocol Registration Data Element Definitions</a>, <a href=\"https://prsinfo.clinicaltrials.gov/expanded_access_definitions.html\" onclick=\"openNewWindow('https://prsinfo.clinicaltrials.gov/expanded_access_definitions.html'); return false\" title=\"Expanded Access Data Element Definitions - opens new window\">Expanded Access Data Element Definitions</a>, and <a href=\"https://prsinfo.clinicaltrials.gov/results_definitions.html\" onclick=\"openNewWindow('https://prsinfo.clinicaltrials.gov/results_definitions.html'); return false\" title=\"Results Data Element Definitions - opens new window\">Results Data Element Definitions</a> for help with the data items required to register a study and submit results using the ClinicalTrials.gov Protocol Registration and Results System.</p>\n",
       "<hr style=\"margin-bottom: 1rem; margin-top: 1rem;\"/>\n",
       "<script type=\"text/javascript\">\n",
       "  $(document).ready(function(){\n",
       "    var terms = document.getElementsByClassName(\"glossary__term\");\n",
       "    var definitions = document.getElementsByClassName(\"glossary__definition\");\n",
       "    var i = 0;\n",
       "    var dictionary = \"\";\n",
       "    for (i = 0; i < terms.length; i++) {\n",
       "      var def = definitions[i].innerHTML.replace(\"text-decoration:underline dotted\", \"\");\n",
       "      dictionary += \"<dl>\" + \n",
       "                    \"<dt>\" + terms[i].innerHTML + \"</dt>\" +\n",
       "                    \"<dd>\" + def + \"</dd>\" + \n",
       "                    \"</dl>\";\n",
       "    }\n",
       "\n",
       "    document.getElementById(\"js-glossary-dictionary\").innerHTML = dictionary;\n",
       "\n",
       "  });\n",
       "</script><noscript></noscript>\n",
       "<dl class=\"js-glossary_dictionary\" id=\"js-glossary-dictionary\"><dl><dt>Accepts healthy volunteers</dt><dd>A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates whether people who do not have the <span class=\"term\" data-term=\"condition/disease\" tabindex=\"-1\" title=\"Show definition\">condition/disease</span> being studied can participate in that clinical study.</dd></dl><dl><dt>Active comparator arm</dt><dd>An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> considered to be effective (or active) by health care providers.</dd></dl><dl><dt>Adverse event</dt><dd>An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of time after the study has ended. This change may or may not be caused by the <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> being studied.</dd></dl><dl><dt>Age or age group</dt><dd>A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups:<p>The age groups are: </p><ul><li>Child (birth-17)</li><li>Adult (18-64)</li><li style=\"margin-bottom:-.4em;\">Older Adult (65+)</li></ul></dd></dl><dl><dt>All-cause mortality</dt><dd>A measure of all deaths, due to any cause, that occur during a clinical study.</dd></dl><dl><dt>Allocation</dt><dd>A method used to assign participants to an arm of a clinical study. The types of allocation are <span class=\"term\" data-term=\"randomized allocation\" tabindex=\"-1\" title=\"Show definition\">randomized allocation</span> and nonrandomized.</dd></dl><dl><dt>Arm</dt><dd>A group or subgroup of participants in a clinical trial that receives a specific <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span>, or no intervention, according to the trial's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>.</dd></dl><dl><dt>Arm type</dt><dd>A general description of the clinical trial arm. It identifies the role of the intervention that participants receive. Types of arms include <span class=\"term\" data-term=\"experimental arm\" tabindex=\"-1\" title=\"Show definition\">experimental arm</span>, <span class=\"term\" data-term=\"active comparator arm\" tabindex=\"-1\" title=\"Show definition\">active comparator arm</span>, <span class=\"term\" data-term=\"placebo comparator arm\" tabindex=\"-1\" title=\"Show definition\">placebo comparator arm</span>, <span class=\"term\" data-term=\"sham comparator arm\" tabindex=\"-1\" title=\"Show definition\">sham comparator arm</span>, and <span class=\"term\" data-term=\"no intervention arm\" tabindex=\"-1\" title=\"Show definition\">no intervention arm</span>.</dd></dl><dl><dt>Baseline characteristics</dt><dd>Data collected at the beginning of a clinical study for all participants and for each arm or comparison group. These data include demographics, such as age, sex/gender, race and ethnicity, and study-specific measures (for example, systolic blood pressure, prior antidepressant treatment).</dd></dl><dl><dt>Canceled submission</dt><dd>Indicates that the study sponsor or investigator recalled a submission of <span class=\"term\" data-term=\"study results\" tabindex=\"-1\" title=\"Show definition\">study results</span> before <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> took place. If the submission was canceled on or after May 8, 2018, the date is shown. After submission of study results, a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> cannot be modified until QC review is completed, unless the submission is canceled.</dd></dl><dl><dt>Certain agreements</dt><dd>Information required by the <span class=\"term\" data-term=\"food and drug administration amendments act of 2007, section 801 (fdaaa 801)\" tabindex=\"-1\" title=\"Show definition\">Food and Drug Administration Amendments Act of 2007</span>. In general, this is a description of any agreement between the sponsor of a clinical study and the <span class=\"term\" data-term=\"principal investigator (pi)\" tabindex=\"-1\" title=\"Show definition\">principal investigator</span> (PI) that does not allow the PI to discuss the results of the study or publish the study results in a scientific or academic journal after the study is completed.</dd></dl><dl><dt>Certification</dt><dd>A sponsor or investigator may submit a certification to delay submission of results information if they are applying for FDA approval of a new drug or device, or new use of an already approved drug or device. A sponsor or investigator who submits a certification can delay results submission up to 2 years after the <span class=\"term\" data-term=\"certification/extension first submitted\" tabindex=\"-1\" title=\"Show definition\">certification/extension first submitted</span> date, unless certain events occur sooner. See <a href=\"https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType\" style=\"\" tabindex=\"-1\" target=\"_blank\">Delay Results Type</a> in the Results Data Element definitions for more information about this certification.</dd></dl><dl><dt>Certification/extension first posted</dt><dd>The date on which information about a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> to delay submission of results or an <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span> was first available on ClinicalTrials.gov. ClinicalTrials.gov does not indicate whether the submission was a certification or extension request. There is typically a delay between the date the study sponsor or investigator submitted the certification or extension request and the <span class=\"term\" data-term=\"first posted\" tabindex=\"-1\" title=\"Show definition\">first posted date</span>.</dd></dl><dl><dt>Certification/extension first submitted</dt><dd>The date on which the study sponsor or investigator first submitted a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> or an <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span> to delay submission of results. A sponsor or investigator who submits a certification can delay results submission up to 2 years after this date, unless certain events occur sooner. There is typically a delay between the date the certification or extension request was submitted and the date the information is first available on ClinicalTrials.gov (<span class=\"term\" data-term=\"certification/extension first posted\" tabindex=\"-1\" title=\"Show definition\">certification/extension first posted</span>).</dd></dl><dl><dt>Certification/extension first submitted that met QC criteria</dt><dd>The date on which the study sponsor or investigator first submitted a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> or an <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span> that is consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a certification or extension request one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria. Meeting QC criteria for an extension request does not mean that the National Institutes of Health (NIH) has determined that the request demonstrates good cause. The process for review and granting of extension requests by the NIH is being developed.</dd></dl><dl><dt>City and distance</dt><dd>In the search feature, the City field is used to find clinical studies with locations in a specific city. The Distance field is used to find studies with locations within the specified distance from a city in number of miles. For example, if you choose Illinois as the <span class=\"term\" data-term=\"state\" tabindex=\"-1\" title=\"Show definition\">state</span>, identifying \"Chicago\" as the city and \"100 miles\" as the distance will find all studies listing a location within 100 miles of Chicago.</dd></dl><dl><dt>Clinical study</dt><dd>A research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: <span class=\"term\" data-term=\"interventional study (clinical trial)\" tabindex=\"-1\" title=\"Show definition\">interventional studies</span> (also called clinical trials) and <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational studies</span>.</dd></dl><dl><dt>Clinical trial</dt><dd>Another name for an <span class=\"term\" data-term=\"interventional study (clinical trial)\" tabindex=\"-1\" title=\"Show definition\">interventional study</span>.</dd></dl><dl><dt>ClinicalTrials.gov identifier (NCT number)</dt><dd>The unique identification code given to each clinical study upon <span class=\"term\" data-term=\"registration\" tabindex=\"-1\" title=\"Show definition\">registration</span> at ClinicalTrials.gov. The format is \"NCT\" followed by an 8-digit number (for example, NCT00000419).</dd></dl><dl><dt>Collaborator</dt><dd>An organization other than the <span class=\"term\" data-term=\"sponsor\" tabindex=\"-1\" title=\"Show definition\">sponsor</span> that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.</dd></dl><dl><dt>Condition/disease</dt><dd>The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.</dd></dl><dl><dt>Contact</dt><dd>The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.</dd></dl><dl><dt>Country</dt><dd>In the search feature, the Country field is used to find clinical studies with locations in a specific country. For example,  if you choose the United States, you can then narrow your search by selecting a <span class=\"term\" data-term=\"state\" tabindex=\"-1\" title=\"Show definition\">state</span> and identifying a <span class=\"term\" data-term=\"city and distance\" tabindex=\"-1\" title=\"Show definition\">city and distance</span>.</dd></dl><dl><dt>Cross-over assignment</dt><dd>A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which groups of participants receive two or more interventions in a specific order. For example, two-by-two cross-over assignment involves two groups of participants. One group receives drug A during the initial phase of the trial, followed by drug B during a later phase. The other group receives drug B during the initial phase, followed by drug A. So during the trial, participants \"cross over\" to the other drug. All participants receive drug A and drug B at some point during the trial but in a different order, depending on the group to which they are assigned.</dd></dl><dl><dt>Data Monitoring Committee (DMC)</dt><dd>A group of independent scientists who monitor the safety and scientific integrity of a <span class=\"term\" data-term=\"clinical trial\" tabindex=\"-1\" title=\"Show definition\">clinical trial</span>. The DMC can recommend to the sponsor that the trial be stopped if it is not effective, is harming participants, or is unlikely to serve its scientific purpose. Members are chosen based on the scientific skills and knowledge needed to monitor the particular trial. Also called a data safety and monitoring board, or DSMB.</dd></dl><dl><dt>Early Phase 1 (formerly listed as Phase 0)</dt><dd>A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research used to describe exploratory trials conducted before traditional <span class=\"term\" data-term=\"phase 1\" tabindex=\"-1\" title=\"Show definition\">phase 1</span> trials to investigate how or whether a drug affects the body. They involve very limited human exposure to the drug and have no therapeutic or diagnostic goals (for example, screening studies, microdose studies).</dd></dl><dl><dt>Eligibility criteria</dt><dd>The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both <span class=\"term\" data-term=\"inclusion criteria\" tabindex=\"-1\" title=\"Show definition\">inclusion criteria</span> (which are required for a person to participate in the study) and <span class=\"term\" data-term=\"exclusion criteria\" tabindex=\"-1\" title=\"Show definition\">exclusion criteria</span> (which prevent a person from participating). Types of eligibility criteria include whether a study <span class=\"term\" data-term=\"accepts healthy volunteers\" tabindex=\"-1\" title=\"Show definition\"> accepts healthy volunteers</span>, has <span class=\"term\" data-term=\"age or age group\" tabindex=\"-1\" title=\"Show definition\">age or age group</span> requirements, or is limited by <span class=\"term\" data-term=\"sex\" tabindex=\"-1\" title=\"Show definition\">sex</span>.</dd></dl><dl><dt>Enrollment</dt><dd>The number of participants in a clinical study. The \"estimated\" enrollment is the target number of participants that the researchers need for the study.</dd></dl><dl><dt>Exclusion criteria</dt><dd>A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span>. These are reasons that a person is not allowed to participate in a clinical study.</dd></dl><dl><dt>Expanded access</dt><dd>A way for patients with serious diseases or conditions who cannot participate in a clinical trial to gain access to a medical product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">U.S. Food and Drug Administration (FDA)</span>. Also called compassionate use.  There are different <span class=\"term\" data-term=\"expanded access type\" tabindex=\"-1\" title=\"Show definition\">expanded access types</span>. <p style=\"margin-bottom:-.4em;\">For more information, see FDA <a href=\"https://www.fda.gov/news-events/public-health-focus/expanded-access\" style=\"\" tabindex=\"-1\" target=\"_blank\">Expanded Access: Information for Patients</a>.</p></dd></dl><dl><dt>Expanded access status</dt><dd><ul><li><strong>Available:</strong> <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">Expanded access</span> is currently available for this investigational treatment, and patients who are not participants in the clinical study may be able to gain access to the drug, biologic, or medical device being studied.</li><li><strong>No longer available:</strong> <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">Expanded access</span> was available for this intervention previously but is not currently available and will not be available in the future.</li><li><strong>Temporarily not available:</strong> <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">Expanded access</span> is not currently available for this intervention but is expected to be available in the future.</li><li><strong>Approved for marketing:</strong> The intervention has been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\"> U.S. Food and Drug Administration</span> for use by the public.</li></ul></dd></dl><dl><dt>Expanded access type</dt><dd>Describes the category of <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">expanded access</span> under <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">U.S. Food and Drug Administration (FDA)</span> regulations. There are three types of expanded access: <ul><li><strong>Individual Patients</strong>: Allows a single patient, with a serious disease or condition who cannot participate in a clinical trial, access to a drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>. This category also includes access in an emergency situation.</li><li><strong>Intermediate-size Population</strong>: Allows more than one patient (but generally fewer patients than through a Treatment IND/Protocol) access to a drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>.  This type of expanded access is used when multiple patients with the same disease or condition seek access to a specific drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>.</li><li><strong><a id=\"treatment-ind\" tabindex=\"-1\"></a>Treatment IND/Protocol</strong>: Allows a large, widespread population access to a drug or biological product that has not been approved by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">FDA</span>. This type of expanded access can only be provided if the product is already being developed for marketing for the same use as the expanded access use.</li></ul></dd></dl><dl><dt>Experimental arm</dt><dd>An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives the <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> that is the focus of the clinical trial.</dd></dl><dl><dt>Extension request</dt><dd>In certain circumstances, a sponsor or investigator may request an extension to delay the standard results submission deadline (generally one year after the <span class=\"term\" data-term=\"primary completion date\" tabindex=\"-1\" title=\"Show definition\">primary completion date</span>). The request for an extension must demonstrate good cause (for example, the need to preserve the scientific integrity of an ongoing <span class=\"term\" data-term=\"masking\" tabindex=\"-1\" title=\"Show definition\">masked</span> trial). All requests must be reviewed and granted by the National Institutes of Health. This process for review and granting of extension requests is being developed. See <a href=\"https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType\" style=\"\" tabindex=\"-1\" target=\"_blank\">Delay Results Type</a> in the Results Data Element definitions for more information.</dd></dl><dl><dt>Factorial assignment</dt><dd>A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which groups of participants receive one of several combinations of interventions. For example, two-by-two factorial assignment involves four groups of participants. Each group receives one of the following pairs of interventions: (1) drug A and drug B, (2) drug A and a placebo, (3) a placebo and drug B, or (4) a placebo and a placebo. So during the trial, all possible combinations of the two drugs (A and B) and the placebos are given to different groups of participants.</dd></dl><dl><dt>FDAAA 801 Violations</dt><dd>A FDAAA 801 Violation is shown on a study record when the U.S. Food and Drug Administration (FDA) has issued a Notice of Noncompliance to the responsible party of an applicable clinical trial. A Notice of Noncompliance indicates that the FDA has determined the responsible party was not in compliance with the registration or results reporting requirements for the clinical trial under the Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801).<p>The National Library of Medicine (NLM) is required by FDAAA 801 to add information to a study record about any FDAAA 801 Violation. This information is provided by the FDA. There are three categories of information that may be included:</p><ul><li>Violation: Shown when the FDA issues a Notice of Noncompliance and posts the Notice of Noncompliance on its designated webpage. There are three types of violations:<ul><li>Failure to submit required clinical trial information</li><li>Submission of false or misleading clinical trial information</li><li>Failure to submit primary and secondary outcomes</li></ul></li><li>Correction: Shown when the FDA confirms that the responsible party has updated the study record to correct the violation and posts the correction notice on its designated webpage.  Because of the time for FDA review and processing, there may be a delay between the date when the study record was updated and the addition of correction information to the FDAAA 801 Violation information. </li><li>Penalty: Shown when the FDA imposes a penalty for the violation and posts the penalty notice on its designated webpage.</li></ul></dd></dl><dl><dt>First posted</dt><dd>The date on which the <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> was first available on ClinicalTrials.gov. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.</dd></dl><dl><dt>First submitted</dt><dd>The date on which the study sponsor or investigator first submitted a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the <span class=\"term\" data-term=\"first posted\" tabindex=\"-1\" title=\"Show definition\">first posted</span> date).</dd></dl><dl><dt>First submitted that met QC criteria</dt><dd>The date on which the study sponsor or investigator first submits a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> that is consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</dd></dl><dl><dt>Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801)</dt><dd>U.S. Public Law 110-85, which was enacted on September 27, 2007. Section 801 of FDAAA amends Section 402 of the U.S. Public Health Service Act to expand ClinicalTrials.gov and create a clinical study <span class=\"term\" data-term=\"results database\" tabindex=\"-1\" title=\"Show definition\">results database</span>. For more information on FDAAA 801, see the <a href=\"https://clinicaltrials.gov/ct2/about-site/history\" style=\"\" tabindex=\"-1\" target=\"_blank\">History, Policies, and Laws</a> page on this site.</dd></dl><dl><dt>Funder type</dt><dd>Describes the organization that provides funding or support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting. Organizations listed as <span class=\"term\" data-term=\"sponsor\" tabindex=\"-1\" title=\"Show definition\">sponsors</span> and <span class=\"term\" data-term=\"collaborator\" tabindex=\"-1\" title=\"Show definition\">collaborators</span> for a study are considered the funders of the study. ClinicalTrials.gov refers to four types of funders: <ul><li>U.S. National Institutes of Health</li><li>Other U.S. Federal agencies (for example, Food and Drug Administration, Centers for Disease Control and Prevention, or U.S. Department of Veterans Affairs)</li><li>Industry (for example: pharmaceutical and device companies)</li><li>All others (including individuals, universities, and community-based organizations)</li></ul></dd></dl><dl><dt>Gender-based eligibility</dt><dd>A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates whether eligibility to participate in a clinical study is based a person's self-representation of gender identity or gender (yes, no). Gender is distinct from <span class=\"term\" data-term=\"sex\" tabindex=\"-1\" title=\"Show definition\">sex</span>.</dd></dl><dl><dt>Group/cohort</dt><dd>A group or subgroup of participants in an <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational study</span> that is assessed for biomedical or health outcomes.</dd></dl><dl><dt>Human subjects protection review board</dt><dd>A group of people who review, approve, and monitor the clinical study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>. Their role is to protect the rights and welfare of people participating in a study (referred to as human research subjects), such as reviewing the <span class=\"term\" data-term=\"informed consent form (icf)\" tabindex=\"-1\" title=\"Show definition\">informed consent form</span>. The group typically includes people with varying backgrounds, including a community member, to make sure that research activities conducted by an organization are completely and adequately reviewed. Also called an institutional review board, or IRB, or an ethics committee.<p>For more information, see <a href=\"https://clinicaltrials.gov/ct2/about-studies/learn#Participating\" style=\"\" tabindex=\"-1\" target=\"_blank\">Participating in Studies</a> on this site.</p></dd></dl><dl><dt>Inclusion criteria</dt><dd>A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span>. These are the reasons that a person is allowed to participate in a clinical study.</dd></dl><dl><dt>Informed consent</dt><dd>A process used by researchers to communicate to potential and enrolled participants the risks and potential benefits of participating in a clinical study. <p>For more information, see <a href=\"https://clinicaltrials.gov/ct2/about-studies/learn#Participating\" style=\"\" tabindex=\"-1\" target=\"_blank\">Participating in Studies</a> on this site.</p></dd></dl><dl><dt>Informed consent form (ICF)</dt><dd>The document used in the <span class=\"term\" data-term=\"informed consent\" tabindex=\"-1\" title=\"Show definition\">informed consent</span> or process.</dd></dl><dl><dt>Intervention model</dt><dd>The general design of the strategy for assigning interventions to participants in a clinical study. Types of intervention models include: <span class=\"term\" data-term=\"single group assignment\" tabindex=\"-1\" title=\"Show definition\">single group assignment</span>, <span class=\"term\" data-term=\"parallel assignment\" tabindex=\"-1\" title=\"Show definition\">parallel assignment</span>, <span class=\"term\" data-term=\"cross-over assignment\" tabindex=\"-1\" title=\"Show definition\">cross-over assignment</span>, and <span class=\"term\" data-term=\"factorial assignment\" tabindex=\"-1\" title=\"Show definition\">factorial assignment</span>.</dd></dl><dl><dt>Intervention/treatment</dt><dd>A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.</dd></dl><dl><dt>Interventional study (clinical trial)</dt><dd>A type of <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span> in which participants are assigned to groups that receive one or more <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. The assignments are determined by the study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>. Participants may receive diagnostic, therapeutic, or other types of interventions.</dd></dl><dl><dt>Investigator</dt><dd>A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study <span class=\"term\" data-term=\"principal investigator (pi)\" tabindex=\"-1\" title=\"Show definition\">principal investigator</span>.</dd></dl><dl><dt>Last update posted</dt><dd>The most recent date on which changes to a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the <span class=\"term\" data-term=\"last update submitted\" tabindex=\"-1\" title=\"Show definition\">last update submitted</span> date) and the last update posted date.</dd></dl><dl><dt>Last update submitted</dt><dd>The most recent date on which the study sponsor or investigator submitted changes to a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> to ClinicalTrials.gov. There is typically a delay of a few days between the last update submitted date and when the date changes are posted on ClinicalTrials.gov (the <span class=\"term\" data-term=\"last update posted\" tabindex=\"-1\" title=\"Show definition\">last update posted</span> date).</dd></dl><dl><dt>Last update submitted that met QC criteria</dt><dd>The most recent date on which the study sponsor or investigator submitted changes to a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> that are consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</dd></dl><dl><dt>Last verified</dt><dd>The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span> of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span> is shown as <span class=\"term\" data-term=\"unknown\" tabindex=\"-1\" title=\"Show definition\">unknown</span>.</dd></dl><dl><dt>Listed location countries</dt><dd>Countries in which research facilities for a study are located. A country is listed only once, even if there is more than one facility in the country. The list includes all countries as of the <span class=\"term\" data-term=\"last update submitted\" tabindex=\"-1\" title=\"Show definition\">last update submitted</span> date; any country for which all facilities were removed from the <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> are listed under <span class=\"term\" data-term=\"removed location countries\" tabindex=\"-1\" title=\"Show definition\">removed location countries</span>.</dd></dl><dl><dt>Location terms</dt><dd>In the search feature, the Location terms field is used to narrow a search by location-related terms other than Country, State, and City or distance. For example, you may enter a specific facility name (such as National Institutes of Health Clinical Center) or a part of a facility name (such as Veteran for studies listing Veterans Hospital or Veteran Affairs in the facility name). Note: Not all <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study records</span> include this level of detail about locations.</dd></dl><dl><dt>Masking</dt><dd>A clinical trial design strategy in which one or more parties involved in the trial, such as the investigator or participants, do not know which participants have been assigned which interventions. Types of masking include: open label, single blind masking, and double-blind masking.</dd></dl><dl><dt>NCT number</dt><dd>A unique identification code given to each clinical study record registered on ClinicalTrials.gov. The format is \"NCT\" followed by an 8-digit number (for example, NCT00000419). Also called the <span class=\"term\" data-term=\"clinicaltrials.gov identifier (nct number)\" tabindex=\"-1\" title=\"Show definition\">ClinicalTrials.gov identifier</span>.</dd></dl><dl><dt>No intervention arm</dt><dd>An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants does not receive any <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> during the clinical trial.</dd></dl><dl><dt>Observational study</dt><dd>A type of <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span> in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to a specific <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">interventions/treatment</span>.<p>A <span class=\"term\" data-term=\"patient registry\" tabindex=\"-1\" title=\"Show definition\">patient registry</span> is a type of observational study.</p></dd></dl><dl><dt>Observational study model</dt><dd>The general design of the strategy for identifying and following up with participants during an <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational study</span>. Types of observational study models include cohort, case-control, case-only, case-cross-over, ecologic or community studies, family-based, and other.</dd></dl><dl><dt>Other adverse event</dt><dd>An <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse event</span> that is not a <span class=\"term\" data-term=\"serious adverse event\" tabindex=\"-1\" title=\"Show definition\">serious adverse event</span>, meaning that it does not result in death, is not life-threatening, does not require inpatient hospitalization or extend a current hospital stay, does not result in an ongoing or significant incapacity or interfere substantially with normal life functions, and does not cause a congenital anomaly or birth defect; it also does not put the participant in danger and does not require medical or surgical intervention to prevent one of the results listed above.</dd></dl><dl><dt>Other study IDs</dt><dd>Identifiers or ID numbers other than the <span class=\"term\" data-term=\"nct number\" tabindex=\"-1\" title=\"Show definition\">NCT number</span> that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.</dd></dl><dl><dt>Other terms</dt><dd>In the search feature, the Other terms field is used to narrow a search. For example, you may enter the name of a drug or the NCT number of a clinical study to limit the search to <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study records</span> that contain these words.</dd></dl><dl><dt>Outcome measure</dt><dd>For <span class=\"term\" data-term=\"clinical trial\" tabindex=\"-1\" title=\"Show definition\">clinical trials</span>, a planned measurement described in the protocol that is used to determine the effect of an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> on participants. For <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational studies</span>, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include <span class=\"term\" data-term=\"primary outcome measure\" tabindex=\"-1\" title=\"Show definition\">primary outcome measure</span> and <span class=\"term\" data-term=\"secondary outcome measure\" tabindex=\"-1\" title=\"Show definition\">secondary outcome measure</span>.</dd></dl><dl><dt>Parallel assignment</dt><dd>A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which two or more groups of participants receive different interventions. For example, a two-arm parallel assignment involves two groups of participants. One group receives drug A, and the other group receives drug B. So during the trial, participants in one group receive drug A \"in parallel\" to participants in the other group, who receive drug B.</dd></dl><dl><dt>Participant flow</dt><dd>A summary of the progress of participants through each stage of a clinical study, by study <span class=\"term\" data-term=\"arm\" tabindex=\"-1\" title=\"Show definition\">arm</span> or <span class=\"term\" data-term=\"group/cohort\" tabindex=\"-1\" title=\"Show definition\">group/cohort</span>. This includes the number of participants who started, completed, and dropped out of the study.</dd></dl><dl><dt>Patient registry</dt><dd>A type of <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational study</span> that collects information about patients' medical conditions and/or treatments to better understand how a condition or treatment affects patients in the real world.</dd></dl><dl><dt>Phase</dt><dd>The stage of a clinical trial studying a drug or biological product, based on definitions developed by the <span class=\"term\" data-term=\"u.s. food and drug administration (fda)\" tabindex=\"-1\" title=\"Show definition\">U.S. Food and Drug Administration (FDA)</span>. The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: <span class=\"term\" data-term=\"early phase 1 (formerly listed as phase 0)\" tabindex=\"-1\" title=\"Show definition\">Early Phase 1 (formerly listed as Phase 0)</span>, <span class=\"term\" data-term=\"phase 1\" tabindex=\"-1\" title=\"Show definition\">Phase 1</span>, <span class=\"term\" data-term=\"phase 2\" tabindex=\"-1\" title=\"Show definition\">Phase 2</span>, <span class=\"term\" data-term=\"phase 3\" tabindex=\"-1\" title=\"Show definition\">Phase 3</span>, and <span class=\"term\" data-term=\"phase 4\" tabindex=\"-1\" title=\"Show definition\">Phase 4</span>. <span class=\"term\" data-term=\"phase not applicable\" tabindex=\"-1\" title=\"Show definition\">Not Applicable</span> is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.</dd></dl><dl><dt>Phase 1</dt><dd>A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials that focus on the safety of a drug. They are usually conducted with healthy volunteers, and the goal is to determine the drug's most frequent and <span class=\"term\" data-term=\"serious adverse event\" tabindex=\"-1\" title=\"Show definition\">serious adverse events</span> and, often, how the drug is broken down and excreted by the body. These trials usually involve a small number of participants.</dd></dl><dl><dt>Phase 2</dt><dd>A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials that gather preliminary data on whether a drug works in people who have a certain <span class=\"term\" data-term=\"condition/disease\" tabindex=\"-1\" title=\"Show definition\">condition/disease</span> (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a <span class=\"term\" data-term=\"placebo\" tabindex=\"-1\" title=\"Show definition\">placebo</span>) or a different drug. Safety continues to be evaluated, and short-term <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse events</span> are studied.</dd></dl><dl><dt>Phase 3</dt><dd>A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.</dd></dl><dl><dt>Phase 4</dt><dd>A <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phase</span> of research to describe clinical trials occurring after FDA has approved a drug for marketing. They include postmarket requirement and commitment studies that are required of or agreed to by the study sponsor. These trials gather additional information about a drug's safety, efficacy, or optimal use.</dd></dl><dl><dt>Phase Not Applicable</dt><dd>Describes trials without FDA-defined <span class=\"term\" data-term=\"phase\" tabindex=\"-1\" title=\"Show definition\">phases</span>, including trials of devices or behavioral interventions.</dd></dl><dl><dt>Placebo</dt><dd>An inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> being studied.</dd></dl><dl><dt>Placebo comparator arm</dt><dd>An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives a <span class=\"term\" data-term=\"placebo\" tabindex=\"-1\" title=\"Show definition\">placebo</span> during a clinical trial.</dd></dl><dl><dt>Primary completion date</dt><dd>The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the <span class=\"term\" data-term=\"primary outcome measure\" tabindex=\"-1\" title=\"Show definition\">primary outcome measure</span>. Whether the clinical study ended according to the <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span> or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The \"estimated\" primary completion date is the date that the researchers think will be the primary completion date for the study. </dd></dl><dl><dt>Primary outcome measure</dt><dd>In a clinical study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, the planned outcome measure that is the most important for evaluating the effect of an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span>. Most clinical studies have one primary outcome measure, but some have more than one.</dd></dl><dl><dt>Primary purpose</dt><dd>The main reason for the <span class=\"term\" data-term=\"clinical trial\" tabindex=\"-1\" title=\"Show definition\">clinical trial</span>. The types of primary purpose are: treatment, prevention, diagnostic, supportive care, screening, health services research, basic science, and other.</dd></dl><dl><dt>Principal investigator (PI)</dt><dd>The person who is responsible for the scientific and technical direction of the entire clinical study.</dd></dl><dl><dt>Protocol</dt><dd>The written description of a clinical study. It includes the study's objectives, design, and methods. It may also include relevant scientific background and statistical information.</dd></dl><dl><dt>Quality control (QC) review</dt><dd>National Library of Medicine (NLM) staff perform a limited review of submitted <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study records</span> for apparent errors, deficiencies, or inconsistencies. NLM staff identify potential major and advisory issues and provide comments directly to the study sponsor or investigator. Major issues identified in QC review must be addressed or corrected (see <span class=\"term\" data-term=\"first submitted that met qc criteria\" tabindex=\"-1\" title=\"Show definition\">First submitted that met QC criteria</span> and <span class=\"term\" data-term=\"results first submitted that met qc criteria\" tabindex=\"-1\" title=\"Show definition\">Results first submitted that met QC criteria</span>). Advisory issues are suggestions to help improve the clarity of the record. NLM staff do not verify the scientific validity or relevance of the submitted information. The study sponsor or investigator is responsible for ensuring that the studies follow all applicable laws and regulations.</dd></dl><dl><dt>Randomized allocation</dt><dd>A type of <span class=\"term\" data-term=\"allocation\" tabindex=\"-1\" title=\"Show definition\">allocation</span> strategy in which participants are assigned to the <span class=\"term\" data-term=\"arm\" tabindex=\"-1\" title=\"Show definition\">arms</span> of a clinical trial by chance.</dd></dl><dl><dt>Recruitment status</dt><dd><ul><li><strong>Not yet recruiting:</strong> The study has not started recruiting participants.</li><li><strong>Recruiting:</strong> The study is currently recruiting participants.</li><li><strong>Enrolling by invitation:</strong> The study is selecting its participants from a population, or group of people, decided on by the researchers in advance. These studies are not open to everyone who meets the eligibility criteria but only to people in that particular population, who are specifically invited to participate.</li><li><strong>Active, not recruiting:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but potential participants are not currently being recruited or enrolled.</li><li><strong>Suspended:</strong> The study has stopped early but may start again.</li><li><strong>Terminated:</strong> The study has stopped early and will not start again. Participants are no longer being examined or treated.</li><li><strong>Completed:</strong> The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).</li><li><strong>Withdrawn:</strong> The study stopped early, before enrolling its first participant.</li><li><strong>Unknown:</strong> A study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been <span class=\"term\" data-term=\"last verified\" tabindex=\"-1\" title=\"Show definition\">last verified</span> within the past 2 years.</li></ul></dd></dl><dl><dt>Registration</dt><dd>The process of submitting and updating summary information about a clinical study and its <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, from its beginning to end, to a structured, public Web-based <span class=\"term\" data-term=\"study registry\" tabindex=\"-1\" title=\"Show definition\">study registry</span> that is accessible to the public, such as ClinicalTrials.gov.</dd></dl><dl><dt>Removed location countries</dt><dd>Countries that appeared under <span class=\"term\" data-term=\"listed location countries\" tabindex=\"-1\" title=\"Show definition\">listed location countries</span> but were removed from the <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> by the sponsor or investigator.</dd></dl><dl><dt>Reporting group</dt><dd>A grouping of participants in a clinical study that is used for summarizing the data collected during the study. This grouping may be the same as or different from a study arm or group.</dd></dl><dl><dt>Responsible party</dt><dd>The person responsible for submitting information about a clinical study to ClinicalTrials.gov and updating that information. Usually the study sponsor or investigator.</dd></dl><dl><dt>Results database</dt><dd>A structured online system, such as the ClinicalTrials.gov results database, that provides the public with access to registration and summary results information for completed or terminated clinical studies. A study with results available on ClinicalTrials.gov is described as having the results \"posted.\" <p><strong>Note:</strong> The ClinicalTrials.gov results database became available in September 2008. Older studies are unlikely to have results available in the database.</p></dd></dl><dl><dt>Results delayed</dt><dd>Indicates that the sponsor or investigator submitted a <span class=\"term\" data-term=\"certification\" tabindex=\"-1\" title=\"Show definition\">certification</span> or <span class=\"term\" data-term=\"extension request\" tabindex=\"-1\" title=\"Show definition\">extension request</span>.</dd></dl><dl><dt>Results first posted</dt><dd>The date on which summary results information was first available on ClinicalTrials.gov. There is typically a delay between the date the study sponsor or investigator first submits summary results information (the <span class=\"term\" data-term=\"results first submitted\" tabindex=\"-1\" title=\"Show definition\">results first submitted</span> date) and the results first posted date.</dd></dl><dl><dt>Results first submitted</dt><dd>The date on which the study sponsor or investigator first submits a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> with summary results information. There is typically a delay between the results first submitted date and when summary results information becomes available on ClinicalTrials.gov (the <span class=\"term\" data-term=\"results first posted\" tabindex=\"-1\" title=\"Show definition\">results first posted</span> date).</dd></dl><dl><dt>Results first submitted that met QC criteria</dt><dd>The date on which the study sponsor or investigator first submits a <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> with summary results information that is consistent with National Library of Medicine (NLM) <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit results information one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</dd></dl><dl><dt>Results returned after quality control review</dt><dd>The date on which the National Library of Medicine provided <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> comments to the study sponsor or investigator. The sponsor or investigator must address major issues identified in the review comments. If there is a date listed for results returned after quality control review, but there is not a subsequent date listed for <span class=\"term\" data-term=\"results submitted to clinicaltrials.gov\" tabindex=\"-1\" title=\"Show definition\">results submitted to ClinicalTrials.gov</span>, this means that the submission is pending changes by the sponsor or investigator.</dd></dl><dl><dt>Results submitted to ClinicalTrials.gov</dt><dd>Indicates that the study sponsor or investigator has submitted summary results information for a clinical study to ClinicalTrials.gov but the <span class=\"term\" data-term=\"quality control (qc) review\" tabindex=\"-1\" title=\"Show definition\">quality control (QC) review</span> process has not concluded.<p>The results submitted date indicates when the study sponsor or investigator first submitted summary results information or submitted changes to summary results information. Submissions with changes are typically in response to  QC review comments from the National Library of Medicine (NLM). If there is a date listed for results submitted to ClinicalTrials.gov, but there is not a subsequent date listed for <span class=\"term\" data-term=\"results returned after quality control review\" tabindex=\"-1\" title=\"Show definition\">results returned after quality control review</span>, this means that the submission is pending review by NLM.</p></dd></dl><dl><dt>Secondary outcome measure</dt><dd>In a clinical study's <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.</dd></dl><dl><dt>Serious adverse event</dt><dd>An <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse event</span> that results in death, is life-threatening, requires inpatient hospitalization or extends a current hospital stay, results in an ongoing or significant incapacity or interferes substantially with normal life functions, or causes a congenital anomaly or birth defect. Medical events that do not result in death, are not life-threatening, or do not require hospitalization may be considered serious adverse events if they put the participant in danger or require medical or surgical intervention to prevent one of the results listed above.</dd></dl><dl><dt>Sex</dt><dd>A type of <span class=\"term\" data-term=\"eligibility criteria\" tabindex=\"-1\" title=\"Show definition\">eligibility criteria</span> that indicates the sex of people who may participate in a clinical study (all, female, male). Sex is a person's classification as female or male based on biological distinctions. Sex is distinct from <span class=\"term\" data-term=\"gender-based eligibility\" tabindex=\"-1\" title=\"Show definition\">gender-based eligibility</span>.</dd></dl><dl><dt>Sham comparator arm</dt><dd>An <span class=\"term\" data-term=\"arm type\" tabindex=\"-1\" title=\"Show definition\">arm type</span> in which a group of participants receives a procedure or device that appears to be the same as the actual procedure or device being studied but does not contain active processes or components.</dd></dl><dl><dt>Single group assignment</dt><dd>A type of <span class=\"term\" data-term=\"intervention model\" tabindex=\"-1\" title=\"Show definition\">intervention model</span> describing a clinical trial in which all participants receive the same intervention/treatment.</dd></dl><dl><dt>Sort studies by</dt><dd>In Advanced Search, the Sort studies by option is used to change the order of studies listed on the Search Results page. You can sort by Relevance or Newest First: <ul><li>Relevance: Studies that best match your search terms appear higher in the search results list. This is the default display for all searches.</li><li>Newest First: Studies with the most recent <span class=\"term\" data-term=\"first posted\" tabindex=\"-1\" title=\"Show definition\">First posted</span> dates appear higher in the search results list.</li></ul></dd></dl><dl><dt>Sponsor</dt><dd>The organization or person who initiates the study and who has authority and control over the study.</dd></dl><dl><dt>State</dt><dd>In the search feature, the State field is used to find clinical studies with locations in a specific state within the United States. If you choose United States in the <span class=\"term\" data-term=\"country\" tabindex=\"-1\" title=\"Show definition\">Country</span> field, you can search for studies with locations in a specific state.</dd></dl><dl><dt>Statistical analysis plan (SAP)</dt><dd>The written description of the statistical considerations and methods for analyzing the data collected in the <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span>.</dd></dl><dl><dt>Status</dt><dd>Indicates the current <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span> or the <span class=\"term\" data-term=\"expanded access status\" tabindex=\"-1\" title=\"Show definition\">expanded access status</span>.</dd></dl><dl><dt>Study completion date</dt><dd>The date on which the last participant in a clinical study was examined or received an <span class=\"term\" data-term=\"intervention/treatment\" tabindex=\"-1\" title=\"Show definition\">intervention/treatment</span> to collect final data for the <span class=\"term\" data-term=\"primary outcome measure\" tabindex=\"-1\" title=\"Show definition\">primary outcome measures</span>, <span class=\"term\" data-term=\"secondary outcome measure\" tabindex=\"-1\" title=\"Show definition\">secondary outcome measures</span>, and <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse events</span> (that is, the last participant's last visit). The \"estimated\" study completion date is the date that the researchers think will be the study completion date.</dd></dl><dl><dt>Study design</dt><dd>The investigative methods and strategies used in the clinical study.</dd></dl><dl><dt>Study documents</dt><dd>Refers to the type of documents that the study sponsor or principal investigator may add to their <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span>. These include a study <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span>, <span class=\"term\" data-term=\"statistical analysis plan (sap)\" tabindex=\"-1\" title=\"Show definition\">statistical analysis plan</span>, and <span class=\"term\" data-term=\"informed consent form (icf)\" tabindex=\"-1\" title=\"Show definition\">informed consent form</span>.</dd></dl><dl><dt>Study IDs</dt><dd>Identifiers that are assigned to a clinical study by the study's <span class=\"term\" data-term=\"sponsor\" tabindex=\"-1\" title=\"Show definition\">sponsor</span>, funders, or others. They include unique identifiers from other trial <span class=\"term\" data-term=\"study registry\" tabindex=\"-1\" title=\"Show definition\">study registries</span> and National Institutes of Health grant numbers. Note: ClinicalTrials.gov assigns a unique identification code to each clinical study registered on ClinicalTrials.gov. Also called the <span class=\"term\" data-term=\"nct number\" tabindex=\"-1\" title=\"Show definition\">NCT number</span>, the format is \"NCT\" followed by an 8-digit number (for example, NCT00000419).</dd></dl><dl><dt>Study record</dt><dd>An entry on ClinicalTrials.gov that contains a summary of a clinical study's protocol information, including the <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span>; eligibility criteria; contact information; and, in some cases, summary results. Each study record is assigned a ClinicalTrials.gov identifier, or <span class=\"term\" data-term=\"nct number\" tabindex=\"-1\" title=\"Show definition\">NCT number</span>.</dd></dl><dl><dt>Study registry</dt><dd>A structured online system, such as ClinicalTrials.gov, that provides the public with access to summary information about ongoing and completed clinical studies.</dd></dl><dl><dt>Study results</dt><dd>A <span class=\"term\" data-term=\"study record\" tabindex=\"-1\" title=\"Show definition\">study record</span> that includes the summary results posted in the ClinicalTrials.gov <span class=\"term\" data-term=\"results database\" tabindex=\"-1\" title=\"Show definition\">results database</span>. Summary results information includes <span class=\"term\" data-term=\"participant flow\" tabindex=\"-1\" title=\"Show definition\">participant flow</span>, <span class=\"term\" data-term=\"baseline characteristics\" tabindex=\"-1\" title=\"Show definition\">baseline characteristics</span>, <span class=\"term\" data-term=\"outcome measure\" tabindex=\"-1\" title=\"Show definition\">outcome measures</span>, and <span class=\"term\" data-term=\"adverse event\" tabindex=\"-1\" title=\"Show definition\">adverse events</span> (including <span class=\"term\" data-term=\"serious adverse event\" tabindex=\"-1\" title=\"Show definition\">serious adverse events</span>).</dd></dl><dl><dt>Study start date</dt><dd>The actual date on which the first participant was enrolled in a clinical study. The \"estimated\" study start date is the date that the researchers think will be the study start date.</dd></dl><dl><dt>Study type</dt><dd>Describes the nature of a <span class=\"term\" data-term=\"clinical study\" tabindex=\"-1\" title=\"Show definition\">clinical study</span>. Study types include <span class=\"term\" data-term=\"interventional study (clinical trial)\" tabindex=\"-1\" title=\"Show definition\">interventional studies</span> (also called clinical trials), <span class=\"term\" data-term=\"observational study\" tabindex=\"-1\" title=\"Show definition\">observational studies</span> (including <span class=\"term\" data-term=\"patient registry\" tabindex=\"-1\" title=\"Show definition\">patient registries</span>), and <span class=\"term\" data-term=\"expanded access\" tabindex=\"-1\" title=\"Show definition\">expanded access</span>.</dd></dl><dl><dt>Submitted date</dt><dd>The date on which the study sponsor or investigator submitted a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria.</dd></dl><dl><dt>Title</dt><dd>The official title of a <span class=\"term\" data-term=\"protocol\" tabindex=\"-1\" title=\"Show definition\">protocol</span> used to identify a clinical study or a short title written in language intended for the lay public.</dd></dl><dl><dt>Title acronym</dt><dd>The acronym or initials used to identify a clinical study (not all studies have one). For example, the title acronym for the Women's Health Initiative is \"WHI.\"</dd></dl><dl><dt>U.S. Agency for Healthcare Research and Quality (AHRQ)</dt><dd>An agency within the U.S. Department of Health and Human Services. AHRQ's mission is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used.</dd></dl><dl><dt>U.S. Food and Drug Administration (FDA)</dt><dd>An agency within the U.S. Department of Health and Human Services. The FDA is responsible for protecting the public health by making sure that human and veterinary drugs, vaccines and other biological products, medical devices, the Nation's food supply, cosmetics, dietary supplements, and products that give off radiation are safe, effective, and secure.</dd></dl><dl><dt>Unknown</dt><dd>A type of <span class=\"term\" data-term=\"recruitment status\" tabindex=\"-1\" title=\"Show definition\">recruitment status</span>. It identifies a study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been verified within the past 2 years. Studies with an unknown status are considered closed studies.</dd></dl></dl>\n",
       "<div id=\"page-last-reviewed\">This page last reviewed in December 2020</div>\n",
       "<div id=\"to-top\"><a href=\"#wrapper\">To Top</a></div>\n",
       "<div id=\"for-footer\">\n",
       "<ul class=\"ct-horz-list\">\n",
       "<li style=\"border-left:0;\"><a href=\"/ct2/help/for-patient\">For Patients and Families</a></li>\n",
       "<li><a href=\"/ct2/help/for-researcher\">For Researchers</a></li>\n",
       "<li><a href=\"/ct2/help/for-manager\">For Study Record Managers</a></li>\n",
       "</ul>\n",
       "</div>\n",
       "</div>\n",
       "<div id=\"footer-menu\">\n",
       "<ul class=\"ct-horz-list\">\n",
       "<li><a href=\"/ct2/home\">Home</a></li>\n",
       "<li><a href=\"/ct2/resources/rss\">RSS Feeds</a></li>\n",
       "<li><a href=\"/ct2/sitemap\">Site Map</a></li>\n",
       "<li><a href=\"/ct2/about-site/terms-conditions\">Terms and Conditions</a></li>\n",
       "<li><a href=\"/ct2/about-site/disclaimer\">Disclaimer</a></li>\n",
       "<li><a href=\"https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fabout-studies%2Fglossary\" onclick=\"openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fabout-studies%2Fglossary'); return false\">Customer Support</a></li>\n",
       "</ul>\n",
       "</div>\n",
       "</div>\n",
       "<div id=\"fine-print\">\n",
       "<ul class=\"ct-horz-list\">\n",
       "<li><a href=\"https://www.nlm.nih.gov/copyright.html\" onclick=\"openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false\" title=\"NLM copyright information - opens new window\">Copyright</a></li>\n",
       "<li><a href=\"https://www.nlm.nih.gov/privacy.html\" onclick=\"openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false\" title=\"NLM privacy policy - opens new window\">Privacy</a></li>\n",
       "<li><a href=\"/ct2/accessibility\" title=\"NLM Accessibility\">Accessibility</a></li>\n",
       "<li><a href=\"https://www.nlm.nih.gov/plugins.html\" onclick=\"openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false\" title=\"NLM viewers and players - opens new window\">Viewers and Players</a></li>\n",
       "<li><a href=\"https://www.nih.gov/icd/od/foia/index.htm\" onclick=\"openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false\" title=\"NIH Freedom of Information Act office - opens new window\">Freedom of Information Act</a></li>\n",
       "<li><a href=\"https://www.usa.gov/\" onclick=\"openNewWindow('https://www.usa.gov/'); return false\" title=\"USA.gov - opens new window\">USA.gov</a></li>\n",
       "</ul>\n",
       "<ul class=\"ct-horz-list\">\n",
       "<li><a href=\"https://www.nlm.nih.gov/\" onclick=\"openNewWindow('https://www.nlm.nih.gov/'); return false\" title=\"U.S. National Library of Medicine - opens new window\">U.S. National Library of Medicine</a></li>\n",
       "<li><a href=\"https://www.nih.gov/\" onclick=\"openNewWindow('https://www.nih.gov/'); return false\" title=\"U.S. National Institutes of Health - opens new window\">U.S. National Institutes of Health</a></li>\n",
       "<li><a href=\"https://www.hhs.gov/\" onclick=\"openNewWindow('https://www.hhs.gov/'); return false\" title=\"U.S. Department of Health and Human Services - opens new window\">\n",
       "            U.S. Department of Health and Human Services</a></li>\n",
       "</ul>\n",
       "</div>\n",
       "<script type=\"text/javascript\">__ncbi_sg_gaMode=\"clinicaltrials\"</script>\n",
       "<script src=\"/ct2/html/js/instrumentNCBIBaseJS.min.js?v=2\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "<script src=\"/ct2/html/js/main-glossary.js?v=44\" type=\"text/javascript\"></script><noscript></noscript>\n",
       "<script type=\"text/javascript\">\n",
       "//OnSubmit routine - copy over some useful data and submit\n",
       "function sendSearchPing() {\n",
       "// Get pinger values\n",
       "var cVals = ncbi.sg.getInstance()._cachedVals;\n",
       "var app = cVals['ncbi_app'];\n",
       "var db = cVals['ncbi_db'];\n",
       "var pdid = cVals['ncbi_pdid'];\n",
       "var pcid = cVals['ncbi_pcid'];\n",
       "// Populate search details\n",
       "var searchDetails = {};\n",
       "searchDetails['jsevent'] = 'search';\n",
       "searchDetails['searchtext'] = jQuery('#header-search-query').val();\n",
       "if (app!=null) searchDetails['ncbi_app'] = app.value;\n",
       "if (db!=null) searchDetails['ncbi_db'] = db.value;\n",
       "if (pdid!=null) searchDetails['ncbi_pdid'] = pdid.value;\n",
       "if (pcid!=null) searchDetails['ncbi_pcid'] = pcid.value;\n",
       "// Send ping msg\n",
       "ncbi.sg.ping(searchDetails);\n",
       "};\n",
       "</script>\n",
       "<script src=\"https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd&amp;t=1616789235209\" type=\"text/javascript\"></script></body></html>"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "soup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Term class_ = 'data-glossary-term glossary__term'\n",
    "# Def class_ = 'glossary__definition'\n",
    "\n",
    "test = []\n",
    "\n",
    "for i in soup.find_all(class_='data-glossary-term glossary__term'):\n",
    "    test.append(i.get_text())\n",
    "    get_def = i.find_next(class_='glossary__definition')\n",
    "    test.append(get_def.get_text())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.DataFrame(columns = ['Term', 'Description'])\n",
    "\n",
    "term = []\n",
    "description = []\n",
    "\n",
    "for i in soup.find_all(class_='data-glossary-term glossary__term'):\n",
    "    term.append(i.get_text())\n",
    "    get_def = i.find_next(class_='glossary__definition')\n",
    "    description.append(get_def.get_text())\n",
    "    \n",
    "df['Term'] = term\n",
    "df['Description'] = description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Term</th>\n",
       "      <th>Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Accepts healthy volunteers</td>\n",
       "      <td>A type of eligibility criteria that indicates ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Active comparator arm</td>\n",
       "      <td>An arm type in which a group of participants r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Adverse event</td>\n",
       "      <td>An unfavorable change in the health of a parti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Age or age group</td>\n",
       "      <td>A type of eligibility criteria that indicates ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>All-cause mortality</td>\n",
       "      <td>A measure of all deaths, due to any cause, tha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>Title</td>\n",
       "      <td>The official title of a protocol used to ident...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>Title acronym</td>\n",
       "      <td>The acronym or initials used to identify a cli...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>U.S. Agency for Healthcare Research and Qualit...</td>\n",
       "      <td>An agency within the U.S. Department of Health...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>U.S. Food and Drug Administration (FDA)</td>\n",
       "      <td>An agency within the U.S. Department of Health...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>Unknown</td>\n",
       "      <td>A type of recruitment status. It identifies a ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>121 rows Ã 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Term  \\\n",
       "0                           Accepts healthy volunteers   \n",
       "1                                Active comparator arm   \n",
       "2                                        Adverse event   \n",
       "3                                     Age or age group   \n",
       "4                                  All-cause mortality   \n",
       "..                                                 ...   \n",
       "116                                              Title   \n",
       "117                                      Title acronym   \n",
       "118  U.S. Agency for Healthcare Research and Qualit...   \n",
       "119            U.S. Food and Drug Administration (FDA)   \n",
       "120                                            Unknown   \n",
       "\n",
       "                                           Description  \n",
       "0    A type of eligibility criteria that indicates ...  \n",
       "1    An arm type in which a group of participants r...  \n",
       "2    An unfavorable change in the health of a parti...  \n",
       "3    A type of eligibility criteria that indicates ...  \n",
       "4    A measure of all deaths, due to any cause, tha...  \n",
       "..                                                 ...  \n",
       "116  The official title of a protocol used to ident...  \n",
       "117  The acronym or initials used to identify a cli...  \n",
       "118  An agency within the U.S. Department of Health...  \n",
       "119  An agency within the U.S. Department of Health...  \n",
       "120  A type of recruitment status. It identifies a ...  \n",
       "\n",
       "[121 rows x 2 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv('nih_clinical_trials_glossary.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
